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 Truncal adiposity impairs ventilation in obese adults by altering normal ventilatory 
mechanics.  Leptin, an inflammatory adipocytokine, is elevated in obesity and has been 
shown to alter ventilatory responses to exercise.  Leptin’s bioavailability appears to be 
regulated by its soluble receptor (LRe), which is reduced in obesity.  Roux-en-Y gastric 
bypass surgery (RYGBS) is a weight loss intervention that reduces total fat mass and 
improves several obesity related co-morbidities including pulmonary dysfunction. The 
purpose of this study was to first evaluate the differences between ventilatory responses to 
carbon dioxide (VE/VCO2 slope) during progressive treadmill walking in morbidly obese 
and normal weight females.  Second, we will analyze the relationships between the 
 x
   
VE/VCO2 slope, truncal adiposity, serum leptin, and LRe.  Lastly, we want to evaluate the 
changes in the ventilatory responses to exercise (VE/VCO2 slope), truncal adiposity, serum 
leptin, and LRe 3 months following Roux-en Y gastric bypass surgery. 
 Thirteen obese (OB 37.7 ±11.4 years, 42.0 ± 4.8 kg/m2) and 12 normal weight 
females (NW 36.1 ±8.0 years, 22.8 ± 1.2 kg/m2) participated in this study.  Blood samples 
for measure of fasting serum leptin and soluble leptin receptor were obtained prior to 
exercise.  Cardiopulmonary variables were measured throughout exercise. Regional 
adiposity was determined through dual energy x-ray absorptiometry.   
 Truncal adiposity was significantly greater in the obese group than the normal 
weight group. Serum leptin was greater in the obese group while LRe was lower than the 
normal weight group. The VE/VCO2 slopes were lower in obese group when compared to 
the normal weight group.  There were no significant group differences in maximal 
ventilation, tidal volume or respiratory rate. Stepwise regression determined that truncal 
adiposity accounted for 31.5% of variance in VE/VCO2 slope (R= 0.561, R2 =0.315, p = 
0.004).   At 3 months post-surgery we observed significant reductions in the obese group in 
total percentages of fat, truncal adiposity, serum leptin.  The soluble leptin receptor was 
not changed at any measured time point following RYGBS.  There were no changes in 3 
months post-surgery VE/VCO2 slopes in the obese group.  
 Truncal adiposity, serum leptin and LRe were associated with reduced ventilatory 
responses to weight bearing exercise (VE/VCO2 slope) in obese females when compared to 
normal weight females.  There were no differences between obese and normal weight 
females in maximal minute ventilation, tidal volume or respiratory rate.  This result 
 xi
   
 xii
suggests that differences in VE/VCO2 slopes may not be entirely from maximal pulmonary 
capacity.  Rather, the differences in VE/VCO2 slope may be attributed to truncal adiposity 
and its positive relationship with leptin.  Elevated leptin in the obese group may indicate a 
state of central leptin resistance which has been shown to reduce the ventilatory responses 
to exercise. 
   At 3 months post RYGBS significant reductions in total percent fat, serum leptin, 
truncal adiposity and BMI were observed.  However, despite improvement in fat mass and 
serum leptin there were no changes in the VE/VCO2 slope and LRe at 3 months post 
RYGBS.  Therefore, it is possible that the improvements in body composition and leptin 
following RYGBS were not sufficient to increase ventilation responses to weight bearing 
exercise in obese females. 
 This document was prepared with a Dell Latitude D610® laptop with a Centrino 
processor microchip.  Word processing was performed using Microsoft Word 2000®, 
tables and figures were produced in Microsoft Excel 2000®.  Statistical analysis was 
performed by SPSS® statistical software edition 17.0. 
 Chapter 1 An Introduction to the Review of Literature 
 
 
 
Introduction to a Review of Literature 
 The percentage of United States population diagnosed as being obese is growing 
with over 30% of individuals across all generations above their recommended body fat 
percentage.1  The high prevalence of obesity is commonly correlated with increased 
incidences of cardiovascular, metabolic, psychological, biomechanical and pulmonary 
diseases.1, 2  Either alone or in combination, obesity-related diseases significantly shortens 
an individual’s life and reduce the overall number of healthy years.1   
 Obesity has been shown to have profound adverse effects on respiration.3  
Respiratory mechanics, respiratory muscle strength and endurance, pulmonary gas 
exchange, control of breathing, pulmonary function parameters and exercise capacity have 
been shown to be negatively altered in obese adults. 3  Specifically, morbid obesity (BMI > 
40 kg/m2) has been associated with impaired exercise ventilation; primarily a mismatch in 
ventilatory responses to the dynamic metabolic needs for oxygen delivery and carbon 
dioxide removal.4   The combination of upper body adiposity and a reduced central 
ventilatory drive are central to the etiology of obesity-related exercise hypoventilation.5-7  
Exercise hypoventilation is characterized by a blunted respiratory response to hypercapnia 
and the retention of arterial carbon dioxide and diminished blood oxygen saturation.  Not 
every case of obesity experiences elevated arterial hypercapnia, instead blunted respiratory 
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drive may reduce minute ventilation and subsequent exercise capacity.  This review will 
primarily focus on the current scientific literature related to the impact of obesity, truncal 
adiposity, serum leptin, the soluble leptin receptor and ventilatory responses to exercise. 
 
 
 
 
 
 CHAPTER 2 Review of Literature 
 
 
 
Obesity  
 Globally, the percentage of adults classified as overweight or obese has increased 
annually.2  The concern over the rising trend in obesity stems from the strong link between 
obesity and cardiopulmonary and metabolic diseases.  In the coming years obesity-related 
diseases are likely to continue to produce significant reductions in overall healthy life span 
years, increases in premature death, and global increases in health care costs.1, 8   
 Obesity Classification   
 The varying degrees of obesity and adiposity are commonly classified by indirect 
measures of body composition (e.g., percentages of fat tissue, lean tissue, mineral and 
water) along with the body mass index (BMI).  BMI is determined by dividing body 
weight in kilograms by height in meters squared and is primarily utilized for determination 
of an individual’s risk for obesity-related diseases.  Utilizing BMI, the American College 
of Sports Medicine (ACSM) categorizes males or females as obese with a BMI greater that 
30 kg/m2, as morbidly obese with a BMI greater than 40 kg/m2 and as super obese with a 
BMI greater 50 kg/m2.  The BMI is the most common clinical measure utilized to 
determine obesity in adults and is positively correlated with disease risk.1  ACSM also 
classifies obesity in males and females as a percent body fat greater than 25% and greater 
than 32%, respectively.   
 Body Composition Assessment   
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 Numerous methods are utilized to determine the various combinations of the 
primary components of body composition: fat mass, fat-free mass, total body mineral and 
total body water.   The utility of each body composition method is often dependent on the 
setting and the level of reliability and validity required.  Many assessment methods are 
relatively inexpensive and require minimal time investment (e.g., skinfold measures and 
bioelectrical impedance analysis) while other techniques require expensive equipment and 
skilled professionals (e.g., dual x-ray absorptiometry (DXA) and hydrostatic weighing).   
 For decades hydrostatic weighing, a measure of whole body buoyancy and water 
displacement during water immersion, was regarded as the most valid and reliable 
technique for both clinical and research settings.  More recently, hydrostatic weighing use 
has declined as new technologies have emerged that have reduced the assessment time 
while increasing the precision of the measurement.  Presently, dual x-ray absorptiomitry 
(DXA) is the most widely used in research and considered to be the gold standard for body 
composition research.  DXA utilizes a whole body x-ray source and detector scan to 
estimate fat mass, fat free mass and bone mineral density.  A recent study compared the 
body assessment data of DXA to a four component model utilizing both obese male and 
female adults.  Their findings indicated that DXA produced a prediction error of ± 4.2% 
body fat in both cohorts.  Despite the potential measurement error, DXA remains one of 
the most precise indirect measures of body composition available.   An additional research 
benefit of a DXA assessment is the ability to estimate tissue distributions throughout 
various regions of the human body, thereby providing researchers with the ability to 
evaluate disease risk in relation to fat distribution patterns.    
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Obesity and Weight Loss Surgery 
 Traditionally, reductions in adiposity and improvements in obesity-related co-
morbidities have been primarily sought with programs designed to increase physical 
activity and reduce caloric intake.  However, in many cases of chronic morbid obesity, 
traditional weight loss interventions have been ineffective in producing sustainable long-
term weight loss.9  In such circumstances, many morbidly obese adults, in consultation 
with their physicians, have chosen to undergo surgical weight loss procedures to reduce 
body mass, reverse obesity-related co-morbidities, and improve overall health.   
Since 1998, the number of bariatric surgery procedures performed annually has 
risen each year with nearly 80% of all patients being female.10  There are two techniques 
that account for the majority of surgical weight loss procedures: 1) gastric banding, a 
restrictive procedure used to reduce the amount of food entering the stomach, and 2) 
gastric bypass surgery (GBS) which is both restrictive and malabsorptive as it also 
bypasses a portion of the intestines.  GBS accounts for 80% of reported bariatric 
operations.10 
Gastric Bypass Surgery 
 GBS was initially performed via an open laparotomy where one large trans-
abdominal incision is made.  While there have been several modifications to the original 
laparotomy procedures to reduce the size of the incision and improve healing, recent 
advances in surgical instrumentation have resulted in greater utilization of laparoscopic 
techniques.  Laparoscopic techniques use smaller incisions for surgical tools and a camera 
that allows the surgeon to visualize the surgical field.  The reported benefits of 
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laparoscopic gastric bypass surgery (LGBS) over traditional open GBS includes a shorter 
post-operative recovery time, fewer revisions to repair leaks, tears and stretching of the 
gastric pouch, reduced incidence of infection, quicker return to normal physical activity 
and subsequent greater fitness outcomes, shorter hospital stays, and overall reduced 
procedural cost. 9-11 GBS patients are typically cleared to commence an exercise program 
within one month following surgery.10  For the individual, a reduced recovery time 
promotes the initiation of a wide range of health focused activities such as lifestyle 
physical activity and exercise.   Likewise, for clinical research the rapid recovery 
associated with RYGBS is beneficial for observation of metabolic, cardiovascular, and 
pulmonary improvements.  Thus, the rapid recovery time and significant overall 
improvement in health support LGBS as the strongest procedure in measuring post-
surgical outcomes in clinical research.  
 The most common LGBS procedure is the Roux-en-Y gastric bypass surgery 
(RYGBS) which is malabsorptive and volume restricting.9, 12, 13  Briefly, the RYGBS 
procedure consists of a division of the stomach into a small sized pouch and a bypass of a 
portion of the large intestine.12  Overall, the objective of RYGBS is to modify both the 
quantity of food that the stomach can digest while also reducing intestinal nutrient 
absorption.   
 As a weight loss procedure, RYGBS is capable of producing rapid weight loss and 
a near immediate improvement in several metabolic and cardiovascular risk factors.  
Wittgrove et. al. conducted an extensive review of nearly 700 RYGBS patients and 
observed post-operative weight loss at 6 and 12-month of 60 and 77% excess body  
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weight, respectively.12  Similarly impressive improvement in several common obesity-
related co-morbidities such as gastro-esophageal reflux disease (GERD), diabetes mellitus, 
sleep apnea, hypertension and overall co-morbidities were reduced below clinical 
parameters by 98%, 98%, 98%, 92% and 71% respectively.12  The rise in RYGBS 
procedures in place of laparotomy and gastric banding techniques over the past decade 
may be attributed to a rapid reversal of disease risk factors along with significant 
reductions in total body mass.10  While the majority of research related to weight loss 
surgery has been centered on the impact of various surgical, medical, and nutritional 
patient outcomes in relation to changes in body composition, little research has 
investigated the association between the post-surgical ventilatory improvements. 
Blood Gas Concentrations 
 Cellular and pulmonary respiration is responsible for the expired and inspired 
diffusion of oxygen and carbon dioxide gas from the atmosphere and the systemic 
circuitry, respectively.  At rest, the partial pressure of oxygen (PO2) and carbon dioxide 
(PCO2) is fairly well maintained in most adults (described in Figure 1).   The partial 
pressure of a gas in a gas mixture is the independent pressure that the gas would produce if 
it occupied the space in the blood alone.  For instance, at sea level, room air consisting of 
oxygen, carbon dioxide and nitrogen, has a partial pressure of 760 mmHg which is the sum 
of its three main components:  PO2 - 159 mmHg, PCO2 - 0.3 mmHg and PN2 - 601 
mmHg.14    
 Fick’s law of diffusion describes how partial pressure gradients across tissues 
produce diffusion gradients that subsequently drive the exchange of oxygen and carbon 
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dioxide during respiration.15  The diffusion gradients in the alveolus of the lung along with 
the skeletal muscle arterial and venous capillary membranes drive the exchange of gases 
(Figure 1).15  Further, Fick’s law describes that the flux in partial pressures on both sides of 
a tissue’s membrane will drive the gas from an area of higher concentration to an area of 
lower concentration.  It is this principle that facilitates the cardiorespiratory system’s 
ability to maintain relatively constant oxygen and carbon dioxide concentrations.  
Lung (Alveolus) 
PAO2= 105 mmHg 
PACO2= 40 mmHg 
Arterial Blood 
PAO2= 100 mmHg 
 PACO2= 40 mmHg 
Venous Blood 
PAO2= 40 mmHg 
 PACO2= 46 mmHg 
 
Muscle Capillary 
PAO2= 40 mmHg 
 PACO2= 46 mmHg 
 
 
 
 
 
Figure 1:  Resting partial pressures of oxygen and carbon dioxide throughout the cardiopulmonary system.  
Figure adapted from.14  
 
 Blood Gas Measurement  
 The most accurate measure of the partial pressure of oxygen and subsequent lung 
diffusion capacity in the human body is obtained from arterial blood samples leaving the 
heart.  Likewise, obtaining a venous sample prior to blood entry in the heart would produce 
an equally precise indication of metabolic carbon dioxide production during resting and 
exercising conditions.  This type of blood sampling, however, is not always possible as the 
methods of sampling arterial blood with an inbound catheter is both potentially risky and 
impractical in many research laboratories.  Specifically, arterial blood sampling poses 
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significant risks and discomfort when utilized during weight bearing progressive exercise 
protocols.  To overcome the obvious challenges of the inbound arterial catheter, several 
less invasive techniques have been developed to estimate arterial blood gas concentrations.   
 The first method is an “arterialized” blood sampling technique where the hand is 
warmed through exposure to hot air, water or other warming device.16 The warming of the 
surface of the hand will trigger an opening of subcutaneous capillary beds in an attempt to 
cool the hand through conduction and radiation of redirected systemic blood.  The opened 
capillary beds provide an opportunity to sample mixed arterial and venous blood, a closer 
representation of arterial gas concentrations when compared to venous samples alone.17  
Extracted arterialized blood samples can then be quickly analyzed through a co-oximeter 
blood gas system.  A limitation of the arterialized blood gas sampling technique is that it is 
an invasive assessment that may not always be available within an applied research setting.  
Similar to an inbound arterial catheter, arterialized samples pose risk and are difficult to 
employ with a weight bearing continuous exercise protocol.   
 Arterial gas partial pressures can be estimated non-invasively by measuring end-tidal 
carbon dioxide (PETCO2) and oxygen (PETO2) partial pressures in expired air.18, 19  End-
tidal refers to the volume of CO2 or O2 at the end of a breath and is reported in millimeters 
of mercury (mmHg).  The end-tidal gas measurement method has been shown to be within 
±5% of arterial blood sample measurements at rest and during sub-maximal exercise.  
During progressive exercise, end-tidal gas measurements were shown to slightly 
underestimate CO2 partial pressures when compared to arterial gas samples.18  However, 
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during maximal exercise, end tidal gas measures were shown to produce over and 
underestimate of both oxygen and carbon dioxide tensions when compared to arterial 
measurements.  Despite the potential for error, end tidal gas measurement produce 
acceptable estimates of partial pressures and allows for gas assessment during weight 
bearing exercise protocols.       
Resting Pulmonary Ventilation  
 The classical view of human ventilation (VE) theorized that a complex interaction 
existed between several independent respiratory “centers” in the central nervous system 20.  
It was believed that ventilation was initiated by a dense concentration of centrally located 
independent rhythmogenic neural clusters collectively known as the medulla respiratory 
center (MRC).14, 20  The MRC consisted of four independently functioning neural sub-
groups: the pnuemotaxic center, the apeneustic center, the inspiratory center (preBötzinger 
complex) and the expiratory center (Bötzinger complex).14, 21  The lack of consistent 
evidence supporting this theory of compartmentalized neural sub-groups led researchers to 
theorize that respiration may be the product of a unified ventilatory drive. 21-24  
Specifically, it was hypothesized that ventilation is a product of a single respiratory central 
pattern generator (rCPG) or central rhythm generator.22  The rCPG functions automatically 
and independently to drive basal VE via a diverse neuronal network in the MRC.  The 
rCPG produces a tonic ventilatory stimulus during basal conditions, however under 
increased metabolic demand; the rCPG may be modulated by both voluntary actions and/or 
chemosensitive afferent neurons.   Specific locations of the neuronal networks are not 
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entirely clear; however, it appears the locations commonly referred to the preBötzinger and 
Bötzinger complex within the MRC produce the tonic neuronal impulses of rCPG 
activity.21  The rCPG is described as being both tonically active and fully capable of 
driving basal respiration independent of any central and peripheral feedback.22, 25 In 
contrast, during changing metabolic conditions such a exercise, the rCPG is incapable to 
respond to the complex array of both central and peripheral feedback.26  Thus, the rCPG 
functions as the foundation of ventilatory drive and are easily modifiable by both voluntary 
and involuntary stimuli.  During exercise, the precise gain of the cardiopulmonary system 
is highly dependent on central and peripheral chemoreceptor feedback modifying the rCPG 
to metabolic requirements.27 
Pulmonary Ventilation and Obesity 
 Obesity can significantly impair normal pulmonary function and places great stress 
on the cardiopulmonary system.  Increased adiposity alters normal pulmonary mechanics, 
increases pulmonary resistance, increases work required for breathing, reduces lung 
volumes, alters ventilatory drive and control and reduces exercise capacity.3  The following 
section will attempt to describe the primary mechanisms that alter normal rest and exercise 
ventilation.   
 Impaired Pulmonary Mechanics   
 Increased truncal adiposity produces an increased load for respiratory muscles to 
overcome.3  The increased load was produced a 92% reduction in chest wall compliance in 
morbidly obese adults when compared to predicted values.28  Likewise, reduced chest wall 
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compliance, lung compliance was also reduced by 25% of predicted values.  A recent 
review argued that despite the obvious relationship between greater trunk load and reduced 
chest and lung compliance, the overall impact on inspiration is limited.3  Rather, the 
increased truncal adiposity present a mass threshold with which inspiration must overcome 
and which in most cases of obesity is easily compensated for.  While it would appear that 
increased truncal load is an important contributor to decreased chest wall compliance in 
obese individuals, it does not appear to account for all of the observed impairment in 
pulmonary mechanics.  
 Pulmonary Resistance  
 In comparison to normal weight subjects, obese individuals have been observed to 
have an increased pulmonary resistance in the trachea, the bronchi and the chest wall.  
Additionally, the magnitude of pulmonary resistance is positively correlated with BMI, 
adiposity and the waist to hip ratio.3  The combined effects of one or all of the resistance 
sites are often reported as an overall reduced lung volume.28, 29    Thus, reduced lung 
volumes may alter gas exchange in the lungs and this occurrence may be magnified during 
exercise. 
 Increased Work of Breathing and Reduced Lung Volumes 
 It would seem logical that the combination of reduced chest wall compliance and 
an increased pulmonary resistance would result in an increased metabolic cost of breathing 
in obese individuals.  Likewise, increased chest wall adiposity and subsequent load should 
require greater inspiratory muscle action and energy expenditure.  However, several early 
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studies have demonstrated that this seemingly logical relationship is not always present in 
obesity.30, 31  Kelly et al. demonstrated that when compared to normal weight adults (99% 
of ideal body weight IBW), obese adults (183% IBW) exhibit greater reliance on chest 
muscle action during inspiration coupled with a reduced reliance of diaphragm muscle 
action.30  No significant differences in inspired airway pressure were observed between the 
two groups, indicating that obese adults were able to compensate for decreased chest wall 
compliance independent of greater inspiratory muscle force.  In a earlier study, Sampson et 
al. 31 observed that obese adults portioned their tidal volume to the chest wall rather than 
the diaphragm thereby reducing reliance on abdominal action during inspiration.  This 
finding indicates that obese adults may compensate for reduced chest wall compliance and 
increased abdominal load by altering the distribution of inspired air.  In effect, if such 
compensation exists, the viability of indirect circumference measures (i.e. abdominal girth, 
WHR) as predication tools for potential ventilatory insufficiency may be inadequate.    
Sampson et al. also observed a reduction in overall tidal volumes as a percentage excess 
body mass above ideal body weight.31  Taken in total, these findings indicate that the 
increased work of inspiration in obesity may be compensated for with increased inspiratory 
muscle action and a reduced reliance on diaphragm muscle action.   
 Altered Ventilatory Drive in Obesity 
 Ventilatory drive is a measure of the rise in minute ventilation in response to an 
increased metabolic demand.  Impaired ventilatory drive is characterized by irregular 
respiratory rhythms, shallow breaths that produce reduced tidal volumes, reduced response 
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to hypercapnia (rise in PaCO2) and an overall mismatch in pulmonary response to varied 
and progressive metabolic demands (reduced slope of VE/VCO2).40  Ventilatory drive is 
commonly measured as the rise in minute ventilation (VE (L/min-1) to increased expired 
carbon dioxide (VCO2).  As described earlier, carbon dioxide is a potent stimulator of 
central chemosensitive cells and functions to drive ventilation and increase the volume of 
carbon dioxide expired (VCO2) to maintain PCO2 within normal limits.  Simple linear 
regression analysis of VE and VCO2 (VE/VCO2 slope) is the primary measure reported in 
the scientific literature and has gained prominence as a measure of cardiovascular disease 
risk.32  
 Though no clinical ranges have been established VE/VCO2 slope values in obese 
subjects are often reported in the range of slope values near 17 to the low 23 while lean 
adults are often 25 to 35.32  The VE/VCO2 slope is a product least squares linear regression 
(y = a + bx; b = slope) from the beginning to the end of a progressive exercise protocol.  A 
fairly recent study determined that a VE/VCO2 slope produced from data encompassing an 
entire exercise bout was a stronger predictor of pulmonary function that any segmented 
form of the slope.32  
 In chronic obesity, the VE/VCO2 slope is a preferred assessment of cardiovascular 
fitness and disease risk compared to traditional measures of maximal oxygen uptake 
(VO2max), as the measure is not effort dependent.33, 34  Likewise, in pulmonary research the 
VE/VCO2 slope is indicative of the combined ventilatory responses to meet the metabolic 
demands of a progressive exercise bout.  A recent study reported that VE/VCO2 slope was 
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a strong predictor of cardiorespiratory dysfunction that was not affected by VO2max and 
BMI.35  Given the low relative VO2max, reduced exercise capacity, and potential for limited 
exercise motivation in obesity, a marker of cardiopulmonary function independent of effort 
is beneficial.   
 Reduced Exercise Tolerance  
 The combined obesity-related mechanical impairments and reduced central drive 
produce an overall reduction in exercise capacity. 36-38  Generally it is has been 
demonstrated that at rest, obese individuals consume approximately 25% more oxygen 
than their non-obese counterparts.3  Likewise, during exercise, the increased body mass 
may require greater oxygen consumption at matched workloads and vary between modes 
of exercise.  For example, during non-weight bearing cycle ergometry, percentage of 
VO2max was not significantly different between different workloads when comparing obese 
and normal weight adults.39  In contrast, treadmill walking produced a more pronounced 
effect in obese subjects with lower respiratory rates and a reduce tidal volume compared to 
normal weight adults.40   
Exercise Ventilation 
 Exercise requires a fluid and rapid rise in respiration to facilitate increased gas 
diffusion to match the metabolic demands of oxygen delivery and carbon dioxide 
production23, 26  From the initial moments of physical activity and throughout an entire 
exercise bout, the cardiopulmonary system must maintain the concentrations of arterial 
blood gases at near resting levels (figure 1).  The mechanisms involved in exercise blood 
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gas homeostasis during progressive exercise are not entirely clear; however, the following 
review will attempt to present the generally accepted mechanisms responsible for 
cardiopulmonary action and maintenance of systemic oxygen and carbon dioxide 
concentrations during exercise. 
 Dynamics of Exercise Ventilation 
 At the onset of exercise, increased efferent neuronal activity of skeletal muscle 
motor neurons traveling through the brain stem indirectly stimulate an increase in VE 
above resting levels.25, 41  Likewise, the combined increase of central motor efferent and 
proprioceptive afferent neuronal activity ascending through the brain stem, site of the 
MRC rCPG, appears to co-stimulate the initial rise in VE .41  Evidence supporting the 
indirect stimulation of VE was demonstrated in an exercise model when increased 
respiration occurred prior to any central or peripheral humeral changes.41  This finding 
substantiated early hypothesis that suggested that an increase in mechanoreceptor feedback 
coupled with the efferent stream from the motor cortex appears to be the initial stimulators 
of VE during progressive exercise independent of any humeral factors.42  Functionally, this 
mechanism seems plausible as the uptake of O2 by cells for oxidative phosphorylation and 
the accompanying systemic rise in metabolic CO2 and subsequent reduction in systemic pH 
are not immediate with the onset of exercise Therefore, the motor and sensory activity 
passing through the MRC could provide the indirect initial signal that increases ventilation 
and pulmonary gas diffusion to accommodate metabolic demand.   
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 Several minutes into an exercise bout the peripheral chemoreceptors located in the 
aortic bodies and carotid bodies provide critical humeral feedback to the rCPG and begin 
modulating ventilatory rate.27  The peripheral chemoreceptors cells are predominately 
excitable to alterations in the partial pressure of arterial oxygen (PaO2) and act as the 
primary systemic oxygen sensors.  Aortic chemoreceptors are excitable glomular cells that 
exhibit an exponential increase in depolarization activity as PaO2 drops below resting 
levels (<100 mmHg) although their role may be secondary to the carotid receptors.27  
Carotid chemoreceptors are unique as their excitable cells have been shown to be sensitive 
to both alteration in PaO2 and partial pressures of arterial carbon dioxide (PaCO2).  Carotid 
neuronal cells have shown a rapid and persistent increase in depolarization activity when 
PaO2 drops below 100 mmHg.27  In a recent study it was demonstrated that carotid body 
free nerve endings modified the rCPG with direct afferent action potentials in the MRC in 
response to hypoxic conditions.25  The carotid chemosensors excitability to fluctuations in 
PaO2 is several folds greater than the aortic body and is considered the primary peripheral 
oxygen sensor.27  The excitability of the carotid bodies to hypercapnia (increased PaCO2) 
has been demonstrated in several studies when PaCO2 exceed ~60 mmHg.25  The role of 
carotid bodies during sea level hypercapnia is believed to be secondary to central CO2 
chemosensors, however carotid bodies are believed to be essential for high altitude 
acclimatization.   
 Central chemoreceptor neurons are located throughout the brainstem and are 
sensitive to changes in the cerebral spinal fluid (CSF) concentrations of CO2, K+ and H+.22, 
27   Central chemoreceptors have been observed as being highly concentrated in the ventral 
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lateral medulla, solitary plexes, raphe, nucleus ambiguous, locus coeruleus, hypothalamus 
and the hippocampus.27, 43  Stimulation of chemoreceptor free nerve endings produced 
depolarizations that modulated the rCPG leading to a rise in ventilatory rate.27  Decreased 
pH in the CSF will rapidly depolarize chemosensitive cells in the MRC and produce 
increased magnitude tonic efferent bursts and increased respiratory rate.22  Hypercapnic 
responses during exercise are primarily regulated by the chemosensitve neurons of the 
central nervous system.  As a result, Hypercapnia and subsequent central chemosensitivity 
activity are viewed at the primary efferent drive to increase VE as exercise intensity 
progresses.   
 Measurement of Exercise Ventilation 
 As previous described exercise ventilatory responses are often evaluated by 
assessing the rise in VE to increased metabolic action (VE/VO2 slope), the rise in VE in 
response to hypercapnia (VE/VCO2 slope) and calculated ventilatory and anaerobic 
thresholds.  Several studies have attempted to normalize exercise ventilation in relation to 
overall aerobic work efficiency (∆VO2/ ∆Work), cardiac efficiency (∆HR/∆VO2) and 
ventilatory responses to carbon dioxide (∆VE/∆VCO2) however these markers are intensity 
dependent and subjective to individual effort.4  The following sections will attempt to 
describe the primary methods for quantifying changes in ventilatory and metabolic 
responses to exercise. 
 Ventilatory Threshold 
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 The ventilatory threshold (Tvent) is a point where the rise in VE in response to 
increased VO2 progresses from a linear to an exponential rise.44, 45  Estimation of the 
ventilatory threshold is accomplished by plotting VE over exercise during a progressive 
exercise test.14 During progressive exercise, VE increases linearly up to approximately 50-
65% of VO2max depending on the individual’s cardiovascular fitness.  Thereafter, VE will 
increase exponential up to maximal VE.  The primary stimulus for the exponential rise in 
VE  above Tvent is elusive, however several major contributors have been identified 
including increased acidosis from rising levels of metabolic CO2,  increased lactate 
production and its associated H+, increased circulating potassium (K+) and increased 
muscle fiber recruitment.23  The compensatory hyperventilation often observed above the 
Tvent is stimulated via the central chemoreceptors and the increased PCO2, H+ and K+ in the 
CNS.27  In a comprehensive review on chemoreceptors, it was stated that hypercapnia 
stimulated central chemoreceptors produced the greatest stimulation to the MRC compared 
to all other ventilation stimulation mechanisms.27  The resultant central action in normal 
healthy adults is an exponential rise in ventilation and observed reductions in PaCO2 to 
normative levels (~40 mmHg).   
 An impaired compensatory hyperventilation response has been described when 
ventilation does not exponentially increase with rising PaCO2, eliminating the presence of 
a Tvent .46 Although a complete understanding of the underlying mechanisms is unclear, 
impaired chemosensitivity to CO2 has been described as a primary contributor.4  The 
ventilatory responses to hypercapnia have been reported in healthy adults to produce a 
slope rate of rise of 3 L/min/mmHg and in obese adults with normal ventilatory responses 
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produce a slope rate of rise of 2 L/min/mmHg and in obese adults with a blunted 
ventilatory responses produce a slope rate of rise of < 1 L/min/mmHg.46  The diminished 
VE response to hypercapnia in obese adults is believed to be due to a blunted central 
response resulting in an inadequate coupling of VE to VCO2.  Obesity, genetic 
predisposition and leptin resistance have been proposed as mechanisms that contribute to 
the blunted hypercapnic response.46    
 Anaerobic Threshold 
 Similar to Tvent, the anaerobic threshold (AT) is another non-invasive method 
utilized to assess the cardiopulmonary performance of an individual during a graded 
exercise test (GXT).14, 47  Although the subject of vigorous debate, AT is a commonly 
employed method for determination of the aerobic and anaerobic contributions during 
progressive exercise. One method used to determine the AT is the V-slope method.  The 
V-slope method is utilized to determine the point at which there is a departure from 
linearity when plotting VCO2 against VO2 during graded exercise.44  Wasserman describes 
the AT as a product of an individual’s capacity to deliver oxygen to working muscles, 
utilize mitochondrial aerobic metabolism, produce lactate, remove cellular lactate and 
buffer metabolic CO2 through the bicarbonate buffering system.44  Further, the respiratory 
gas concentrations during progressive exercise are determined by the coupled potential of 
the cardiopulmonary and metabolic systems to respond to a changing systemic pH.  In 
obesity, the AT is an effective tool to describe the cardiopulmonary and metabolic 
responses of an individual during progressive exercise.  Typically, in obese adults, the 
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presence of an AT occurs at a lower relative percentage of VO2max and HRmax when 
compared to non-obese adults.  The combined metabolic and cardiovascular impairments 
of obesity contribute to an earlier onset and greater reliance on non-oxidative metabolism 
during a graded exercise test. 
Obesity-Related Impaired Exercise Ventilation 
 Morbid obesity has been demonstrated in both human and animal studies to be a 
contributing factor to altered resting and exercising ventilatory responses to hypercapnia.36, 
46, 48-50  Common symptoms of obesity-related impaired ventilation are low and irregular 
respiratory rates, impaired ventilation response to hypercapnia and a subjective sense of 
heavy breathing or dyspnea while at rest and exercise.38  Mechanisms that contribute to 
obesity-related impairments in exercise ventilation generally fall into two primary areas; 1) 
chest wall impairment and 2) an inhibited central drive.    
 Chest Wall Impairment  
 Chest wall impairment is a consequence of trunk bound adipose tissue which has 
impedes normal muscular action of inspiration, increases the work of ventilation, reduces 
tidal volumes and induces a more rapid ventilatory muscle fatigue.3, 37, 51, 52  In a recent 
study investigating rapid weight loss following bariatric surgery, abdominal adiposity 
height was assessed by the waist to hip ratio (WHR) and was demonstrated to be a stronger 
predictor of impaired pulmonary function at rest than BMI.52  The authors concluded that 
an increased WHR was associated with a minor ventilatory constraint and lung perfusion 
which produced a larger difference between alveolar and arterial partial pressures of 
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oxygen (∆(PA-a)O 2)  along with PaO2.  However, WHR ratio did not correlate with 
impaired gas exchange in morbidly obese females.  An alternate finding demonstrated that 
adults with the highest BMI’s had the lowest level of impaired ventilation when compared 
to non-obese controls.50  No specific mechanisms were theorized to account for their 
equivocal findings.  However, it could be concluded that mechanisms other than adipose 
tissue airway obstruction and reduced chest wall compliance may contribute to obesity-
related impairments in exercise ventilation.  Despite a consistent and even logical 
relationship between impaired ventilation and trunk bound adipose tissue it is clear that 
other mechanisms may contribute to impaired ventilation in obese individuals. 
 Obesity, Leptin and Impaired Ventilatory Drive 
 Inhibited central ventilatory drive is a complex mechanism and subject to multiple 
interpretations.  However, a growing volume of research has demonstrated that the 
peripheral circulating factor, leptin, may in part regulate ventilation.5  Several animal and 
human studies have demonstrated leptin’s central role as a ventilatory stimulant.5, 7, 53, 54  In 
a knockout mouse model, leptin deficient mice when compared to wild type controls were 
characterized as being obese, hyperphagic (excessive eating) and exhibited shallow and 
irregular respiration.  Direct leptin injections into the medulla respiratory center’s (MRC) 
dorsal structures of the knockout mice produced a dose dependent rise in VE, VT and, 
increased action potentials to inspiratory muscles.54  Likewise, in a similar study of leptin 
knockout mice, direct leptin injections into the CNS rapidly improved VE independent of 
any changes in adiposity.55  Human obesity is not commonly associated with leptin 
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deficiency and reported cases of genetic deficiency are extremely rare.56  Rather, human 
obesity is characterized by elevated serum leptin (hyperleptinemia) coupled with reduced 
concentrations in the CSF.56  Therefore, it is assumed that obesity-related leptin resistance 
in humans is a product of reduced BBB transport and the corresponding result may be 
similar to leptin deficiency observed in animals.   
 In humans, hyperleptinemia has been positively correlated with the obesity 
hypoventilation syndrome (OHS), disordered sleep ventilation and is a prognostic indicator 
for congestive heart failure.34, 57, 58, 58  Obese adults with OHS, have an elevated daytime 
PaCO2 ≥ 45 mmHg and a reduced chemosensitivity to CO2 which results in a diminished 
ventilatory rate and volume.  Obese adults with OHS have been shown to have greater 
concentrations of serum leptin compared to age, gender and percent adipose tissue matched 
non-OHS adults46; however, this study did not take measurements of CSF leptin 
concentrations.  The result is a corresponding rise in daytime hypercapnia in the absence of 
a matched rise in VE.46  OHS presents many of the similar characteristics as an obesity-
related blunted ventilatory response to exercise. 
 Leptin association with impaired ventilation appears to primarily involve blunted 
respiratory responses to hypercapnia but not to hypoxia.  Leptin appears to modulate the 
ventilatory responses to CO2 via direct stimulation of respiration via mechanisms in the 
CNS.59, 60  Several sites within the CNS are believed to have chemosensitive cells; 
however, our understanding of the contribution of each cluster of neurons is incomplete.  
Recent evidence has demonstrated that a cluster of noradrenergic neuronal cells described 
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as the locus coeruleus (LC) play a central role in hypercapnic responses to exercise.61  The 
LC is comprised of several chemosensitive nuclei with nearly 80% of its neurons sensitive 
to hypercapnia.   Further, the LC accounts for nearly 50% of the noradrenergic projections 
of the cardiovascular center.61  A recent study isolated the LC and demonstrated its 
increased ventilatory activity during hypercapnia through acidic focal stimulation.  
Likewise, destruction of the LC removed any ventilatory response to hypercapnia 
independent of any other stimulus.61 These findings supported an earlier report that 
chemosensitive neurons of the LC contributed to nearly half of the central hypercapnic 
response in rats.62  Catecholaminergic neurons believed to exist within the brain stem were 
shown to be primarily responsible for the central chemosensitivity.  It was concluded that 
noradrenergic neurons of the LC modulated hypercapnic responses during non-resting 
conditions.  These finding suggested that the LC might act as the primary sensor to CSF 
CO2 during progressive exercise.   
 Leptin has recently been demonstrated to indirectly regulate central norepipherine 
(NE) efflux by regulating gamma amniobityric acid (GABA) within the CNS.63  Leptin has 
also been shown to both up regulate and down regulate GABA in a location dependent 
manner.  GABA is the predominant neuroinhibitor in the CNS and has been shown to 
reduce NE action through pre-synaptic inhibition.  A reduction in CSF leptin may produce 
elevated GABA levels subsequently reducing NE efflux in the CNS.  Reduced CNS efflux 
from the hypothalamus and downstream locations may reduce the ventilatory response to 
progressive exercise.  In obesity, inhibited leptin transport into CNS may produce a leptin 
deficiency and promote increased GABA synthesis.  GABA is believed to inhibit NE via 
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the GABAA receptor which is highly expressed in the hypothalamus and brain stem.63  
Further research clarifying the role of Leptin, GABA, and ventilation responses to 
hypercapnia is necessary. 
 In summary, impaired exercise ventilation in obesity may result from the combined 
effects of reduced chest wall compliance from elevated concentrations of truncal adiposity 
and a blunted central ventilatory drive.  The combined effects of these two mechanisms 
may be exacerbated during progressive exercise and reduce cardiovascular and ventilatory 
efficiency.  Figure 2 illustrates the proposed model of obesity-related impaired exercise 
ventilation.  
Morbid Obesity BMI > 40 
Increased Mechanical Load 
Chest Wall Impediment 
Hyperleptinemia & 
Leptin Resistance 
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Impaired Exercise Ventilatory 
CO2 Responses 
↓slope VE/VCO2  (ventilatory response to carbon dioxide) 
↓ Minute Ventilation 
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Figure 2. Proposed model for altered ventilatory responses with obesity 
Leptin and Obesity 
 Leptin was first discovered in 1994 and since has gained recognition as an essential 
factor in several inflammatory conditions associated with obesity.64, 65  Leptin’s primary 
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functions are diverse and involve several central and peripheral systems that regulate 
appetite and energy homeostasis.66, 67  It has been hypothesized that leptin may function as 
a single “master” biomarker for the progression of obesity and the subsequent risk for 
related diseases.68, 69   Leptin’s central action appears to be appetite suppression in the 
lateral hypothalamic area (LHA) by inhibition of  neuropeptide-Y (NPY) and agouti-
related peptide (AgRP).70  Plasma leptin values are typically higher in obese compared to 
non-obese adults when matched for age and gender and has commonly been shown to be 
positively correlated with adiposity.71-73  Elevated levels of leptin are strongly correlated 
with many obesity-related diseases such as hypertension, metabolic syndrome, immune 
dysfunction, and chronic heart failure.69, 74  
 Chronic obesity is best viewed as a state of excess energy availability.  Large 
percentages of white adipose tissue (WAT) associated with obesity as an energy storage 
depot that in most cases far exceeds the biological requirements of an individual.  Oddly 
enough, elevated leptin associated with obesity does not appear to inhibit eating 
behavior.75  Current research has described the state of obesity as a chronic pattern of 
endocrine dysfunction.6,8,67  Over the past decade several obesity linked cytokines have 
gained recognition for their potential role as biomarkers for metabolic and cardiovascular 
disease risk  
Leptin Biology 
 Leptin was first observed over four decades ago in mice as an unnamed circulating 
protein in plasma that appeared to play a role in regulating body weight.76  Initial 
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observations suggested that when this protein was absent in the plasma it appeared to lead 
to the progression of obesity in mice.76  It was not until 1994 that this protein factor was 
cloned and described to the scientific community as leptin.64  From that 1994 study, Zhang 
et al. identified leptin as an adipocyte secreted hormone that appeared to circulate in 
proportion to the quantity of adipose tissue.64  It was theorized that leptin exerted both 
satiety and metabolic stimulating actions in the hypothalamus affirming earlier 
observations.64, 76  The discovery of leptin changed the way the scientific community 
viewed adipose tissue and expanded our understanding of its role beyond caloric storage.  
Indeed, adipose tissue is now considered the largest endocrine gland involved in regulating 
many diverse essential cellular mechanisms.66, 77  Leptin’s primary role is in appetite 
regulation; however it also appears to be a ventilatory stimulant.54 
 Leptin circulates in the serum in both a free or active form and bound to the soluble 
leptin receptor (LRe) as an inactive or complex form.69  The free form of leptin is 
attributable for the majority of its central and peripheral signaling actions.   Leptin exerts 
its intracellular effects via cell signaling cascades initiated through binding with the long 
form receptor LRb.74, 78  The long form leptin receptor is highly concentrated in the central 
nervous system and the primary binding cite for leptin.74   
 Leptin enters the CNS through binding with the leptin receptor LRa via endocytosis 
with cells of the blood brain barrier.79  It is believed that leptin’s ventilatory role is 
centrally located and its transport across the BBB is essential for its bioavailability.  
Impaired leptin transport into the CNS is a central mechanism in the hyperleptinemia and 
leptin resistance paradigm commonly reported in obese adults.79   
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 Leptin Synthesis and Secretion 
 Leptin is the product of the ob or also the lepr gene and is circulated in the plasma 
with a molecular mass of 16 kDa with no known homologue amino acid sequence to any 
other proteins.74  Leptin is secreted primarily through white adipose tissue (WAT); 
however, synthesis and secretion has been observed in the gastric epithelium, brown 
adipose tissue, skeletal muscle, liver, placenta and recently the brain.56, 80  Leptin secreted 
from non-adipose peripheral sites are believed to serve a more autocrine or paracrine 
function rather than endocrine.81  The local actions of non-WAT leptin secretion are 
unknown.  Leptin is secreted in a diurnal pattern that appears to follow the typical feeding 
schedule of most humans.82  The lowest plasma levels are observed in the mid-morning 
while the highest concentrations are typically after midnight. 
 Basal levels of total leptin in non-obese (BMI<30 kg/m2) subjects typically 
circulates at concentration in the range of 5-15 ng/ml in both a free and carrier protein 
bound form.  In contrast, leptin has been observed in obese individuals (BMI > 30 kg/m2) 
at concentrations over 200 ng/ml.74  No clear clinical plasma leptin guidelines have been 
established for increased risk beyond commonly observed non-obese normative ranges.   
 Leptin Receptors 
Leptin binds to six leptin receptors (LR) that belong to the cytokine class I receptor 
family designated as LRa, LRb, LRc, LRd, LRe, and LRf, that are found commonly 
throughout the body.74  All leptin receptor isoforms share the same extracellular binding 
site indicating that active leptin is the only ligand.  The primary differences between the 
various isoforms is the protein structure of their carboxy-terminus intracellular domain, 
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cell signaling cascades and the various tissue expressing each protein.74, 78, 83  The receptor 
isoforms are also products of a single lepr (ob) gene and are individually expressed from 
alternative mRNA splicing or proteolytic processing.84  Five of the six receptor isoforms 
share the same transmembrane domains.  The LRe, leptin’s soluble receptor, is the only 
isoform that lacks both a transmembrane and intracellular domain.78   
The highest expression of leptin receptors has been observed in the nuclei of the 
hypothalamus.74, 78  The hypothalamic pathways and nuclei associated with leptin binding 
act as the “dual center” of appetite regulation.  The lateral hypothalamic area (LHA) 
functions as the “hunger center” and the ventromedial hypothalamic region (VMN) as the 
“satiety center”.70, 84  Leptin’s direct signaling action in the LHA and VMN is the origin of 
acute and chronic energy intake and energy expenditure regulation.70, 85  
Leptin Receptor Classification   
Leptin receptors fall into there distinct classifications: secreted or soluble, short 
and, long forms.  The only secreted isoform is LRe (sometimes distinguished as LRs) and 
it circulates as a soluble plasma bound leptin carrier.78  The soluble receptor LRe is cleaved 
from the extracelluar domain of the membrane bound LRa and is believed to be the only 
serum bound leptin carrier protein.86  Recent evidence has sited the importance of LRe for 
the blood brain barrier (BBB) transport of leptin in the central nervous system.87   Using a 
mouse model, Tu et al. observed reduced leptin cell surface binding to LRa and a 
subsequent reduction in endocytotic transport into the CSF of mice exhibiting high 
concentrations of LRe.87  Leptin and LRe bound complexes appear to be inactive with 
reduced bioavailability and subsequent BBB transport. The importance of LRe 
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concentrations may further extend our understanding of hyperleptinemia and leptin 
resistance as observed in obese adults.  The primary short form leptin receptor (LRa) plays 
a key role in transporting leptin across the blood brain barrier into the cerebral spinal 
fluid.79  Banks et al. described LRa function in an animal model where inhibited LRa 
receptor expression at the BBB halted central activity of leptin.  A subsequent direct 
injection of leptin into the cerebral spinal fluid returned leptin activity to the hypothalamic 
hunger centers.88  These findings indicated that altered LRa expression at the BBB may be 
the central site for obesity-related leptin resistance. Treatments aimed at increasing BBB 
LRa expression may represent a possible therapeutic intervention for obesity prevention.83  
A further discussion on leptin resistance will follow later in this review.  The role of the 
remaining short form receptors (LRc, d, and f) remain unclear despite similar extracelluar 
protein structure to the long form receptors.74, 78 The long form receptor, specifically LRb 
is the most active and potent form and is the only receptor with intercellular signaling 
pathways.78  LRb is highly expressed in a wide range of tissues such as brain, skeletal 
muscle, liver, stomach, adipose tissue, blood vessels, lungs and kidneys.   However the 
greatest concentrations are observed in the nuclei of the LHA and VMN of the 
hypothalamus.78  For example, hypothalamic LRb deficient mice tend to be obese, 
hyperphagic, and do not respond to leptin infusion.89  
LRb is the most significant of the receptor isoforms with the widest theorized roles 
in appetite regulation and energy expenditure.  Long form leptin receptors (LRb) have been 
described as ubiquitously expressed on almost all tissues.  The highest concentrations of 
LRb are expressed in the nuclei of the “dual center” of the hypothalamus and appear to 
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control food intake.75, 90  Other higher brain centers also express LRb signaling receptors in 
the control of autonomic and neuroendocrine function.90  The LRb has been theorized as an 
integral moderator for a wide range of leptin’s peripheral physiological mechanisms 81.  
For instance, LRb expression in skeletal muscle appears to contribute to increased fatty 
acid oxidation and cellular glucose and fatty acid uptake.91  Similarly, LRb is also highly 
expressed in the kidney’s collecting ducts and is theorized to directly modify blood 
osmolarity, blood pressure and mean arterial pressure.92 The prevalence of LRb expression 
has demonstrated leptin as a seemingly “master hormone” involved in several 
physiological mechanisms.81 
Despite leptin’s influence on several biological mechanisms, not all receptor 
signaling pathways are similar.  An LRb intracellular signaling differential exists and is 
dependent on the specific cell type expressing the receptor.93  The LRb associated with 
skeletal muscle activates the AMP-activated protein kinase (AMPK) phosphorylation 
cascade.94  Skeletal muscle expressing LRb has been shown to increase AMPK-dependent 
beta oxidation and non-insulin glucose uptake.95  However, LRb expression within the 
central nervous system functions through the janus kinase autophosphorylation and insulin 
receptor substrate 1 and 2 signaling pathways.83, 96 Animal models have also demonstrated 
leptin’s activation of several other signaling cascades such as: mitogen-activated protein 
kinase (MAPk), extracellular signal-regulated kinase (ERK), Akt family of kinases and 
phosphoinositide 3-kinase (PI3’) although their specific signaling actions are presently 
unclear.93   
Leptin, Appetite and Energy Balance 
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 The primary actions of leptin are often described as an anti-starvation hormone in 
the regulation of appetite control.  Leptin’s satiety actions have been described as a 
“brake” on the bodies’ continual drive to take in nutrients.75  Konturek et al. described the 
human appetite and homeostatic energy system as being geared toward constant weight 
gain and the storage of calories and only a few mechanisms exist that actually encourages 
weight loss.70  Konturek’s theory states that not until modern times has food been so 
plentiful in the civilized world and as a result most individuals consume far more calories 
than needed to sustain life.  Likewise, the human’s innate drive to store energy has not 
evolved with the modern feeding habits of today’s lifestyles.70  The result is the rapid 
progression of human obesity and a corresponding state of biochemical confusion.  
 Leptin and Appetite Regulation 
Leptin’s appetite regulatory actions in the “dual center” of the central nervous 
system (CNS) are signaled via LRb in the lateral hypothalamic area (LHA) and ventral 
medulla nuclei (VMN).  Leptin exerts its action in the CNS through the cell signaling 
mechanisms the janus kinase 2 (JAK2) and signal transducer and activator of transcription 
3 (STAT3) and the insulin substrate receptor (IRS) protein and phosphatidylinositol 3-
kinase (PI3’-K) mechanisms.83, 93  Leptin’s inhibitory effects act on the LHA to decrease 
the potent orexigenic (appetite stimulator) stimulators neuropeptide y (NPY) and agouti-
related peptide (AgRP) (figure 3).   In contrast, leptin’s signaling in the VMN acts to 
produce a sensation of satiation through the prohormone preopiomelanocortin (POMC) 
along with the neurotransmitter peptide cocaine and amphetamine regulated transcript 
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(CART) stimulation of the potent anorexigenic (appetite inhibitor) α- melanocyte 
stimulating hormone (α-MSH). 83, 88 
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Figure 3. Appetite regulation of leptin; adipose tissue synthesis, secretion into systemic 
 circulation, endocytosis with BBB, inhibit neuropeptide Y and agouti related peptide, and produce 
 satiety. 70 
 
The process of acute appetite regulation is fairly complex; however, we are 
convinced it begins with a meal.  Post-prandial stomach distention is believed to trigger the 
stomach’s mechanoreceptors that provide afferent signals to the CNS through the enteric 
nervous system (ENS) of the gastrointestinal tract to inhibit the drive to eat.70  It is 
believed that the ENS afferent signals via the vagal nerve have two primary functions.  
First, the ENS functions to provide direct afferent feedback to the brain on the current 
capacity of the stomach and in doing so co-regulate the drive “to fill or not fill”.70  
Secondly, the ENS is believed to trigger the release of the gut peptide cholecystokinin 
(CCK).  CCK among its primary role in signaling pancreatic action and begin the process 
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of gastric emptying is believed to stimulate leptin secretion.  Both CCK and leptin initiate 
the vagal nerve afferent signaling of stomach energy balance and begin the acute central 
regulation of appetite.97, 98 Both leptin and CCK receptors have been observed along the 
entire length of the vagal nerve.98 
Cholecystokinin release appears to stimulate the synthesis of leptin from adipocytes 
as both CCK and leptin secretion are increased both post-prandial and during infusion 
studies.70  Like leptin, CCK also appears to inhibit the central drive to eat through similar 
signaling pathways.  CCK, similar to leptin, has been shown to directly inhibit in the LHA 
the production of NPY and AgRP.85  The potential shared satiety action by CCK and leptin 
in the hypothalamus is supported by similar cell signaling action through the JAK-STAT3 
cell signaling mechanisms.81   
Insulin is considered a primary mediator of leptin synthesis and secretion.99   For 
example, following food ingestion the immediate pancreatic release of insulin is followed 
by an acute elevation of plasma leptin.85  Research has further demonstrated that leptin 
secretion may be stimulated indirectly by insulin-mediated glucose uptake and 
metabolism.100  The up regulation of leptin via accelerated glucose metabolism has been 
observed in both human and animal studies.100, 101  This relationship was further supported 
within a mouse model where exogenous insulin injection produced a subsequent rise in 
plasma leptin.   It has been shown that post-prandial leptin and insulin are positively 
correlated in both obese and non-obese adults.75  Interestingly, it was shown that leptin 
levels were elevated following a high carbohydrate, low fat meal compared to high fat 
meals.102  Further investigations have demonstrated that a carbohydrate-type dependent 
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response may exist.  It had shown that consumption of high-fructose based meals initiated 
a post-prandial rise in ghrelin and reduced leptin concentration.103  These responses would 
fail to inhibit the drive to eat and may contribute to excessive caloric consumption.  In 
contrast, these effects were attenuated when glucose based meals were served.103 Muccioli 
et al. cited these observations as potential contributors to overeating and increased caloric 
storage.  In a comprehensive review combined insulin and leptin responses are reduced 
following fructose compared to other saccharide forms.104  
 Leptin’s Peripheral Actions 
 Leptin’s diverse endocrine effects have also been shown to alter several metabolic 
functions in the pancreas, liver, skeletal muscle and the CNS.80  In non-obese individuals 
the diverse peripheral actions of leptin generally contribute to the normalization of plasma 
glucose and fatty acids.  Leptin indirectly alters plasma fuel levels through increased 
hepatic glucose production and reduce lipogenesis through increased lipolysis.80  Leptin’s 
activation of hepatic lipolysis had been demonstrated in a mouse model with enlarged fatty 
livers.  Chronic leptin treatment reduced the overall liver size and lipid concentrations.105   
Leptin’s direct action in the pancreas has not been confirmed.  However, several 
reviews site evidence of leptin’s potential role in improving insulin sensitivity.73, 105  In 
leptin and insulin deficient mice, chronic leptin infusion decreased blood glucose, 
glycosylated hemogloblin and circulating insulin levels.105  No clear mechanisms have 
been discussed to explain the effect of leptin in improving insulin sensitivity.   
 Leptin’s chronic responses to homeostatic changes in energy balance are 
fairly similar to its acute responses of appetite regulation.  Both long and short term 
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regulation follows the similar hypothalamic neuroendocrine pathway of the “dual center” 
for appetite regulation.  The over consumption of food far beyond necessary levels 
stimulates the bodies mechanisms to store energy as white adipose tissue.70 
 Leptin Resistance 
 Lastly, the previously stated “leptin resistance” has garnered much interest over the 
past decade with little understanding of its etiology.68  The correlation with 
hyperleptinemia and adiposity has produced many theoretical mechanisms that contribute 
to this state of leptin resistance and subsequent reduced hormonal action.   
 Early leptin resistance theories narrowed the potential resistant mechanism to the 
BBB: specifically leptin’s inability to be transported across the BBB to the 
hypothalamus.79  The leptin receptor LRa functions as the primary blood brain barrier 
transporter protein and is found commonly throughout the cells of the BBB.78  Reduced 
LRa BBB expression has been indicated as a potential contributor to reduced leptin action 
in the hypothalamus.56, 79  Banks described leptin resistance as a mechanism of altered 
BBB transport activity and subsequent reductions in CNS concentrations.79  Mechanisms 
contributing to the decreased CSF levels of leptin are elusive; however, a relationship 
between the ratio of the concentration of serum leptin to cerebral spinal fluid 
concentrations is evident.46  In obese adults lower CSF concentrations (CSF/serum ratio 
0.011  0.002) were observed when compared to lean adults (CSF/serum ratio 0.047  
0.01).106  This evidence suggested that despite elevated serum leptin levels, reduced leptin 
transport across the BBB may be critical in the obese leptin resistant adult.  Recent 
research presented compelling evidence that in obesity, leptin BBB transport is greatly 
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diminished and is associated with the soluble protein leptin transporter LRe.87  From these 
findings it was suggested that LRe bound leptin appears to be unable to either bind with 
LRa or activate endocytosis with the BBB or the combined complex inhibited LRa 
expression entirely.87  Inhibited leptin transport across the BBB in humans may reduce the 
CSF concentrations and mimic the responses observed in knockout mice models.  The 
recent findings would support the diminished CSF to serum leptin concentration ratios 
observed by Caro et. al. over a decade ago.106  A graphical summary of the proposed model 
of leptin resistance is depicted in figure 4. 
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Figure 4.  Proposed model of obesity linked basal hyperleptinemia and subsequent impaired central 
leptin action. 
In summary, leptin resistance in obesity is most likely: 1) an impaired BBB 
transport mechanism antagonized by the bound leptin and soluble receptor complex’s 
reduction of the bioactive form of the hormone, 2) a down regulation of BBB LRa activity 
and reduced trafficking of leptin into the CNS, and 3) resistant or down regulated receptors 
in the CNS.   
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Leptin and Exercise 
 With leptin’s previously described relationship with obesity and its role in energy 
homeostasis it is important to look at a possible interaction with exercise.  The relationship 
between an exercise effect and changes in circulating leptin are not so apparent as several 
equivocal findings present opposing theories.107, 108  First, exercise has been suggested to 
directly reduce leptin concentrations independent of either weight loss or caloric deficit.109-
111  Second, it has been shown that exercise does not reduce leptin independent of changes 
in adiposity and energy balance.107, 108, 112, 113  The contrasting results are only complicated 
further by the diverse research designs and data collection methods utilized to administer 
the exercise interventions.111, 112, 114, 115 In a review of leptin and a possible exercise effect, 
no consistent findings have been observed and the majority of the findings indicate there is 
no direct effect of exercise on circulating leptin.107   
 The majority of findings that reported reduced leptin following exercise have 
similar 24-48 hour post data collection time points.  With the tight relationship between 
leptin and acute nutritional state, isolating a chronic or long term exercise effect would 
require long term post-exercise follow up.  In a comprehensive review, it was suggested 
that any investigations into an exercise specific effect may best be observed within a 
caloric balanced and monitored model with data collection several days post.107  It has 
been shown that acute changes in nutritional state (i.e. starvation, anorexia nervosa) can 
lead to a rapid decrease in circulating leptin.116  However, in both of these conditions basal 
leptin levels were returned to normal following feeding. Therefore, in order to observe a 
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chronic or even acute exercise effect independent of caloric deficit it may be necessary to 
extend measurement beyond 24 and 48 hours post. 
 Exercise Regulating Leptin; Dependent on Energy Balance   
 The list of observed findings that indicated no direct leptin-exercise relationship is 
extensive.108, 112, 117, 118  The majority of these studies have investigated an exercise effect 
using models of matched energy balance, negative energy balance, short duration moderate 
intensity, high intensity exercise, and program based long-term exercise interventions.119, 
120   
 One of the earlier reports investigated a short term exercise intervention in healthy 
young sedentary women.112  Hilton et al. employed an exercise intervention that consisted 
of 4 days of several 30-minute treadmill bouts at 70% of VO2max or the caloric expenditure 
equivalent of 30 kcal·kg·bw per day.112  From this study it was suggested that no 
significant reduction in leptin occurred within the energy balanced sub-group that 
consumed 45 kcal·kg·bw a day.  However, within the same study, an energy deficient sub-
group that consumed only 30 kcal·kg·bw did demonstrate reduced leptin following 4-days 
of sub-maximal exercise.  The study used rigorous control methods as both subjects were 
sequestered for blood sample for 24 hours following exercise.112  The caloric cost of the 
physical activity was estimated through accelerometers and meals were provided through 
Ensure™, a commercially available liquid meal substitute.  The findings indicated that 
there was no leptin reducing exercise effect independent of caloric cost.  A possible 
consideration regarding these findings is that the model investigated healthy non-obese 
women at a very low caloric cost exercise intervention.  It could be possible that the 
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combined overnight stays and reduced normal activity along with the moderate intensity 
physical activity were still within the normal energy expenditure range of the subjects.  If 
this indeed was the case, the intervention was not extensive enough to disrupt energy 
homeostasis in the energy balanced group.  Indeed, several studies have demonstrated that 
an exercise effect with matched energy balance may need to exceed 1000 calories.113   
 In a similar short term moderate intensity intervention, young lean males were 
compared to older obese males.118  The intervention model consisted of 7 days of 60-
minute treadmill running at an estimated caloric cost of 450 kcals.  Subjects were 
instructed to follow their normal diet while adding an additional 450 calories to account for 
the exercise intervention.  No specific basal or exercise caloric assessments were 
performed either pre or post-exercise.  From this study, it was concluded that an 
intervention of sub-maximal exercise with no changes in body mass and enhanced insulin 
action does not reduce plasma leptin.118   The strength of this highly cited study is limited 
in the lack of caloric control and precision in energy balance, limited exercise intensity and 
heterogeneous groups.   
 In a more recent 7-month exercise intervention with obese young women, similar 
findings were observed with the observed leptin reductions dependent on reduced fat 
mass.120  Kondo’s model utilized a 7 month intervention of 4-5 days of 30-minute 
minimum sub-maximal exercise.  No attempts to control for energy balance were made and 
groups were not stratified based on total weekly exercise time.  From this study, a post-
exercise leptin reduction of 25% along with a decreased fat percentage of 14.1% was 
observed.120  It was concluded that 7-months of exercise intervention did not reduce leptin 
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independent of fat mass changes.  These findings are not surprising since circulating leptin 
is positively correlated with percent of total adipose tissue.66  Therefore, the findings may 
be better suited to conclude that this intervention effectively reduced the percentage of 
leptin producing tissue before any measured direct exercise effect.   
 Lastly, no reductions in plasma leptin was observed in obese males following a 
short term sub-maximal exercise bout (58% of VO2max ).121  Total caloric energy cost was 
estimated at 600 kcals per day and failed to induce any significant reductions in leptin.  
Cumulatively, these studies have demonstrated the diverse approaches employed to 
determine an acute and or chronic exercise effect at reducing leptin.  
 Exercise regulates Leptin: Direct Effect   
The body of literature that has measured an exercise effect at lowering leptin 
independent of weight loss, BMI and fat changes is limited.  However, in a rigorously 
controlled study that involved 4 different energy balance treatments, it was demonstrated 
that moderate exercise with matched energy balance lowered post 48 hr plasma leptin.111  
Additional findings from this study clarified many of the discrepancies observed in 
previous research on leptin and exercise.  One of the treatments investigated a no-exercise 
state with a positive energy balance (calories beyond resting requirements) that produced 
elevated plasma leptin levels.111   
In contrast, another treatment in the same study matched exercise with a negative 
energy balance, which produced the lowest circulating plasma leptin of all four 
treatments.111  This finding demonstrated the rapid response of leptin to increase the 
hunger drive within an acute state of exercise-induced energy deficit.  It is clear from these 
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findings that leptin, although sensitive enough to respond to acute changes in energy 
balance may produce longer term changes with a matched caloric expenditure and intake.  
Finally, this same study observed a 20% reduction in 24 hour leptin values with a 
treatment of exercise expenditure matched to energy intake for energy balance.111  The 
findings indicted that exercise may have a direct effect on adipose tissue secretion of leptin 
and that the effect is manifested 24-48 hours post-exercise.   
Two confirming studies had observed similarly delayed reduced leptin following a 
single bout of exercise.122, 123 Within both models, a single bout of combined maximal and 
endurance exercise that expended 800-1500 calories was tested.  Both 24 and 48 hours 
post-exercise leptin concentrations were reduced with the greatest reduction occurring at 
48 hours post-exercise  (30% and 40%, respectively).122, 123  Neither study measured 
plasma leptin concentrations beyond 48 hours nor were unable to comment on the duration 
of the exercise effect.122, 123  
Lastly, in a study of obese sedentary males, significant reductions in leptin were 
observed following 16 months of endurance exercise training.124 Strong negative 
correlations were observed between leptin reduction and total hours per week of exercise 
training along with improvement in cardiovascular fitness.  Interestingly, reduced leptin 
was not correlated with changes in percentage of body fat and insulin reductions despite 
improvement in both.124  
 The effect exercise has on plasma leptin spans the entire range from no observed 
independent change to a direct dependent change.  However, a significant finding from the 
existing body of literature is the importance of the research model used.  For example, long 
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term, low intensity, short duration exercise has shown leptin reducing effects.124  However, 
similar exercise intensities during shorter treatment periods have measured no specific 
leptin changes.117  It is possible that chronic changes of circulating leptin require time to 
modify a “set point” of energy balance and thus require long-term exercise treatments.  In 
contrast, shorter acute exercise models may require a substantial caloric expenditure of 800 
kcals or greater to modify post-exercise plasma leptin concentrations.  
Summary 
 Obesity poses a global threat to the overall health of adults.  Over the past decade 
RYGBS has gained prominence as an intervention that rapidly reduces obesity-related 
disease risk factors and excess body weight.  In obesity, the combined impediment of high 
concentrations of adipose tissue, coupled with systemic endocrine inflammation 
significantly strains the biomechanical and physiological systems of the human body.  
Specifically, these combined obesity-related mechanisms evidently impair both resting and 
exercise pulmonary responses.  It has been clearly shown that truncal adiposity 
significantly reduces the overall mechanical function of the chest wall and the muscles of 
inspiration and expiration.3   However, truncal adiposity alone does not appear to be the 
primary factor associated with reduced pulmonary ventilatory responses during exercise.  
On additional factor that has the potential to contribute to ventilatory impairments in obese 
individuals is leptin.  Leptin is found in high concentrations in the serum of obese adults 
and several reports have shown correlations between the waist to hip ratio, body mass 
index, total adiposity, and basal leptin concentrations and reduced pulmonary responses at 
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rest and during non-weight bearing exercise.4, 5, 52  However, little research has investigated 
the combined associations of leptin, and its soluble receptor along with total mass of 
truncal adiposity and fat-free mass on cardiopulmonary response to weight bearing 
exercise.  Lastly, the effect of reducing truncal and total body fat and serum leptin on 
exercise ventilation following RYGBS during an acute bout of weight-bearing exercise has 
not been evaluated.   
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Title: A comparison of VE/VCO2 slopes in normal weight and morbidly obese females: the 
effect of truncal adiposity, serum leptin, and the soluble leptin receptor. 
Abstract 
Truncal adiposity impairs ventilation in obesity by altering normal ventilatory mechanics.  
Leptin, an inflammatory adipocytokine, is elevated is obesity and alters exercise 
ventilatory responses during exercise.  Leptin appear to be regulated by its soluble receptor 
(LRe), which is reduced in obesity. The purpose of this study was to investigate the 
relationships between ventilatory responses to carbon dioxide (VE/VCO2 slope), truncal 
adiposity, leptin, and LRe in morbidly obese and normal weight females during 
progressive treadmill walking.  Methods: Thirteen obese (OB 37.7 ±11.4 years, 42.0 ± 4.8 
kg/m2) and 12 normal weight females (NW 36.1 ±8.0 years, 22.8 ± 1.2 kg/m2) participated 
in this study.  Blood samples for measure of fasting serum leptin and soluble leptin 
receptor were obtained prior to exercise.  Cardiopulmonary variables were measured 
throughout exercise. Regional adiposity was determined via dual energy x-ray 
absorptiometry.  Results:  Truncal adiposity was significantly greater in OB (OB 34.5 ±6.7 
kg, NW 7.7 ±1.3 kg, p= 0.00). Serum leptin was greater in OB (OB 43.4 ±13.5 ng/ml, NW 
9.04 ±3.9 ng/ml, p= 0.00) and LRe was lower in OB (OB 3.1 ±0.57 ng/ml, NW 5.4 ±1.1 
ng/ml, p= 0.00). VE/VCO2 slopes were lower in OB (OB 22.48 ± 2.9 ng/ml, NW 25.7 ±2.5 
ng/ml, p= 0.005). There were no significant group differences in ventilation, tidal volume 
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or respiratory rate. Stepwise regression determined that truncal adiposity accounted for the 
31.5% of variance in VE/VCO2 slope (R= 0.561, R2 =0.315, p = 0.004). Conclusion: 
Truncal adiposity, serum leptin and LRe were related to differences in ventilatory response 
to exercise in normal weight and obese females. 
Introduction 
 Obesity continues to be a major public health concern with nearly a third of all 
Americans above their ideal body weight.1  Chronic obesity is linked to cardiopulmonary 
and metabolic diseases, as well as certain forms of cancer.2  Obesity has also been shown 
to alter cardiopulmonary responses to graded exercise with documented ventilatory 
impairments that have the potential to impact activities of daily living and health-related 
quality of life.3-5  Ventilatory impairments observed in obese subjects include a reduced 
tidal volume (VT) and ventilation (VE L/min-1), and improved exercise ventilatory response 
to carbon dioxide (VE/VCO2 slope).  Much debate surrounds the specific mechanisms that 
produce these ventilatory alterations; however it appears that a combination of elevated 
truncal adiposity and reduced central chemosensitivity to carbon dioxide are the primary 
mechanisms.     
 Increased truncal fat mass has been shown to reduce normal mechanical action and 
compliance of the chest wall.6  Additionally, increased truncal adiposity results in 
adipocyte infiltration of ventilatory muscles, reduced diaphragm muscle force, esophageal 
confinement, increased pulmonary pressure and greater metabolic demand per breath.4, 6-10  
Zavorsky et al. recently demonstrated that the waist to hip ratio (WHR), a common 
measure of adipose tissue distribution, was associated with poor alveolar gas exchange at 
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rest and proved to be a stronger predictor of ventilatory impairment than BMI or waist 
circumference.25   
 In contrast to the physical impairments posed by truncal adiposity, recent evidence 
from both human and animal studies suggests that the adipocytokine leptin may contribute 
to obesity-related ventilatory impairments.11-13  Leptin’s central role as a regulator of 
appetite and energy metabolism is well documented; however, leptin has also recently been 
described as a ventilatory stimulant that appears to act upon central chemoreceptors.14  In 
obesity, serum leptin levels are several fold greater than in normal weight adults, and 
hyperleptinemia is associated with a reduced leptin action and a corresponding state of 
leptin resistance as a result of a reduction in the soluble leptin receptor (LRe).15,16  While 
the role of LRe is still not entirely clear, it has been shown to reduce leptin transport across 
the blood brain barrier thus reducing leptin concentration in the cerebral spinal fluid 
(CSF).17 A reduced CSF leptin concentration may exacerbate central leptin resistance and 
contribute to obesity-related ventilatory impairments.18  In a recent study, elevated basal 
leptin in obese subjects was associated with a blunted ventilatory response to hypercapnia 
at rest.11  Furthermore, in an animal model, obese leptin deficient mice exhibited a reduced 
respiratory drive, respiratory rate, tidal volume and diminished response to both hypoxia 
and hypercapnia; all of which were reversed following direct injection of leptin into the 
CNS.19  
 The VE/VCO2 slope is a common measure employed to assess the response of 
ventilation to carbon dioxide production.  The predictive strength of the VE/VCO2 slope on 
cardiopulmonary function was first reported in heart failure patients where it was shown to 
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not be limited by patient effort.20  Recent studies with obese adults have similarly 
demonstrated that the VE/VCO2 slope is reduced when compared to normal weight controls 
which suggest a blunted ventilatory response to carbon dioxide.21   
 The purpose of this study was to compare the ventilatory responses of morbidly 
obese and normal weight females during an acute bout of weight-bearing exercise 
(treadmill walking).  Additionally, measures of truncal adiposity, serum leptin, and the 
soluble leptin receptor were evaluated to further understand the factors that might 
contribute to the obesity-related alterations in the ventilatory response to graded exercise.  
We hypothesized that morbidly obese females would demonstrate a reduced VE/VCO2 
slope in response to graded exercise compared to normal weight controls and that the 
differences in the VE/VCO2 slope between the two groups would be related to increased 
truncal adiposity, elevated basal serum leptin concentration, and decreased basal soluble 
leptin receptor concentration. 
Methods  
 Subjects 
 Normal weight (NW; BMI < 25 kg/m2) and morbidly obese (OB; BMI ≥ 40 kg/m2) 
females were recruited to participate in this study.  All subjects completed an informed 
consent prior to participation in the study.  All procedures were approved by the Virginia 
Commonwealth University Institutional Review Board (Appendix A).  Subjects were 
required to visit the laboratory on one occasion between 7:00 – 8:00 AM after an 8 hour 
fast.  American College of Sports Medicine criteria for exercise testing and physician 
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supervision were followed.  Due to the increased level of risk, a cardiologist supervised all 
graded exercise tests performed on morbidly obese individuals.  
 Anthropometrics 
 Height was measured to the nearest 0.5 cm using a fixed stadiometer and body 
weight was determined to the nearest 0.5 kg using a digital scale.  Abdominal, waist, and 
hip circumference measures were assessed at standard anatomical locations to the nearest 
0.5 cm.22  Waist to hip ratio and body mass index (kg/m2) were determined by standard 
calculations. 
 Body Composition 
 Whole and regional quantities of adipose tissue and lean mass were obtained from 
dual energy x-ray absorptiometry analysis (DXA; GE Lunar, iDXA, United Kingdom).  
Truncal adiposity and lean tissue percentages (without bone mineral content) were 
manually determined from iDXA software calculations based on the following 
standardized anatomical sites: 1) upper body superior limits were the soft tissue boundary 
of the shoulders excluding the neck and head, 2) lateral boundaries began at the 
glenohumeral joints and continued along the soft tissue of the trunk with separation 
between the arms, 3) the inferior boundary of the trunk was established from the most 
superior point of the suprailiac crest. 
 Blood Analysis 
 A 7-ml resting blood sample was obtained via venapuncture from an antecubital 
vein with a 21 gauge Vacutainer® blood collection set into a serum separator tube 
(Vacutainer, BD Inc, Franklin Lakes, NJ).  After 30 minutes at room temperature, the 
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whole blood sample was centrifuged at 1000x g for 15 minutes.  Following separation, 
serum samples were aliquoted into sample tubes and frozen (-80° C) until later analysis.  
 Measurement of leptin and soluble leptin receptor weas performed using 
Quantikine ELISA kits per manufacturer specifications (R&D Systems, Inc, Minneapolis, 
MN).  A microplate reader with an absorbance wavelength of 450 nm and automatic 
correction wavelength of 540 nm (Bio-Rad 680 XR, Bio-Rad Laboratories, Hercules, CA) 
was utilized to analyze all samples .  Samples were run in duplicate and the intra assay 
correlations of variation for each assay were averaged at 5.75% with all standard curve 
correlation coefficients > 0.998.  A single capillary blood sample was collected from the 
finger 1-minute following exercise test termination for determination of maximal lactate 
response (Lactate Scout, SensLab, Leipzig, Germany). 
 Cardiopulmonary Testing 
 Each subject was monitored with a 12-lead EKG during the graded exercise test.  
Heart rate was obtained at the end of every minute and blood pressure and ratings of 
perceived exertion (6-20 Borg scale) was obtained at the end of every stage.  Continuous 
breath by breath measurement of VO2 (L/min-1 & ml/kg/min-1), VCO2 (L/min-1), VE (STPD 
L/min-1), VT (L/min-1), respiratory rate (breaths per minute), and RER (VCO2/ VO2) was 
obtained during the exercise test (Vmax Encore, Sensormedics, Yorba Linda, CA). All 
cardiorespiratory variables were averaged over 20 seconds for analysis.  Maximal oxygen 
consumption (VO2max L/min-1 & ml/kg/min-1) was determined as the highest 20 sec 
averaged oxygen consumption value.  Maximal lactate > 8.0 mM, maximal RPE > 18, 
maximal RER > 1.15, and a maximal HR value within ± 10 beats per minute of age-
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predicted maximal heart rate (220 – age) were used to assess subject effort during the 
graded exercise test. 
 Morbidly obese subjects were monitored with a 12-lead EKG during the graded 
exercise test.  Heart rate response in normal weight subjects was determined with a heart 
rate monitor (Polar Electro, Sweden). 
 Derived variables 
 The VE (STPD L/min-1)/VCO2 (L/min-1) slope was determined by least squares 
linear regression (y = a + bx) with the 20 second averages from the entire exercise bout.  
 Statistical Analysis 
 Independent samples t-tests were utilized to analyze anthropometric and 
cardiorespiratory variables between the two groups.  Correlations between VE/VCO2 slope 
and total and truncal adiposity, basal serum leptin, the soluble leptin receptor, and 
cardiorespiratory fitness (VO2max) were performed with Pearson Product Moment 
Correlations.  Stepwise linear regression was used to analyze the prediction of the 
independent variables leptin, LRe, and truncal adiposity on the dependent variable 
ventilatory drive (VE/VCO2 slope). Significance was set with an alpha of p ≤ 0.05.  All 
statistical analyses were performed using SPSS 17.0 statistical software (SPSS Inc., 
Chicago, IL). 
Results 
 Anthropometric measures 
 All anthropometric variables are provided in Table I. The obese group had 
significantly greater total percent fat (OB 51.2 ± 4.4%, NW 29.9 ± 4.0 % p< 0.001), total 
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body mass (OB 116.63 ±16.5 kg, NW 66.49 ±5.19 kg, p< 0.001), total trunk mass (OB 
56.9 ±10.8 kg, NW 19.1±3.0 kg, p< 0.001 ), total truncal lean mass (OB 30.1 ±8.0 kg, NW 
19.1 ±1.5 kg, p< 0.001), and truncal adiposity (OB 34.5 ±6.6 kg, NW 7.7 ±1.2kg, p< 
0.001) than the normal weight group.  Likewise, the obese group had significantly greater 
abdominal, hip, and waist girth measurements and WHR.  There were no significant age or 
height differences between the two groups.   
 Cardiopulmonary Responses 
 Cardiopulmonary responses of the two groups to the graded exercise test are 
provided in Table II.  There were significant differences between the two groups in VO2max 
(ml/kg/min-1), total exercise time, and VE/VCO2 slopes (Figure I).   
 Blood Markers 
 Serum leptin levels (Figure I, leptin OB 43.4 ±13.5, NW 9.04 ±3.9 ng/ml, p< 
0.001) were significantly greater while soluble leptin receptor levels (Figure II), LRe OB 
3.11 ±0.57, NW 5.37 ±1.13 ng/ml, p< 0.001) were significantly lower in the obese group 
than in the lean group.    
 Correlations 
 VE/VCO2 slope was negatively correlated with serum concentrations of leptin (r = -
0.483, p = 0.015) and positively correlated with the soluble leptin receptor (r = 0.470, p = 
0.018).  Similar positive correlations with VE/VCO2 slope were observed with truncal 
adiposity (r = -0.562, p = 0.004), but not with truncal lean tissue mass (r = -0.299, p = 
0.156).  A negative correlation existed between VE/VCO2 slope and total body mass (r = -
0.604, p = 0.001) BMI (r = -0.571, p = 0.003) and percent total adipose tissue (r = -0.631, p 
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= 0.001).  Surprisingly, there was no correlation with VE/VCO2 slope and the WHR (r = -
0.136, p = 0.517).  A relationship between VE/VCO2 slope was observed with total exercise 
test time (r = 0.451, p = 0.024) but not with relative or absolute VO2max (r = 0.394, p = 
0.052), Tvmax (r = -0.113, p = 0.592) or HRmax (r = 0.177, p = 0.399).  Results from the 
stepwise linear regression indicated that truncal adiposity alone accounted for 31.5% (r = 
.561, r2 = .315, p = 0.004) of variance in ventilatory response to exercise.  Our other 
independent variables, leptin and LRe, were statistically excluded from the stepwise 
analysis as they did not contribute any greater variance in the dependent variable than 
truncal adiposity.  
Discussion 
 To our knowledge, this is the first study to evaluate truncal adiposity, serum leptin, 
soluble leptin receptor (LRe), and the VE/VCO2 slope during progressive weight bearing 
exercise in morbidly obese and normal weight females.  The VE/VCO2 slope was 
significantly reduced in the obese group and truncal adiposity accounted for the greatest 
variance in ventilatory responses to exercise between the two groups.  Interestingly, there 
were no significant differences between the groups in maximal minute ventilation, 
respiratory rate and tidal volume suggesting that the differences in ventilatory responses to 
exercise between the two groups were independent of mechanical limitations or altered 
lung volumes.    
 We present for the first time that truncal adiposity accounted for nearly a third of 
the variance in ventilatory responses to exercise, further expanding on the previously 
reported relationship between total percent fat and reduced alveolar ventilation.23  In the 
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majority of previous studies, truncal adiposity was indirectly measured as either the WHR 
or as total fat percentage.24, 25  Both measures may fail to provide a direct indication of 
truncal adiposity and may over and/or under estimate the potential impairment on exercise 
ventilation.4, 9, 26  Analyzing exercise ventilation responses in relationship to a direct 
measure of truncal adiposity as in this study may better explain the relationship between 
increased chest mass and pulmonary mechanics.   
 A closer examination of the relationship between adiposity and ventilatory 
response to exercise provided a few other findings.  First, despite the significant correlation 
between truncal adiposity and VE/VCO2 slope, there was relationship between truncal 
adiposity and minute ventilation, respiratory rate or tidal volume.  Further, there were no 
significant differences between maximal ventilation, tidal volume and respiratory rate in 
the obese and normal weight groups.  This may indicate that mechanical limitations such 
as chest wall compliance, inspiratory muscle force and reduced thoracic space were not 
limiting factors in our obese cohort.  This result is in contrast to a previous review that had 
implicated truncal adiposity and obesity with reduced ventilatory rate and volume and 
subsequent impaired alveolar gas exchange compared to normal weight controls.6  Our 
results suggest that truncal adiposity modified the VE/VCO2 slope independent of any 
direct mechanical impact on ventilatory volume and rate.   
 We observed that truncal adiposity and percent fat were both correlated with serum 
leptin and LRe.  This relationship may better describe the possible association between 
truncal adiposity and the VE/VCO2 slope.  This is a critical distinction as abdominal or 
visceral adiposity is associated with greater secretion of pro-inflammatory cytokines (e.g. 
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leptin).27  Therefore, in our cohort, truncal adiposity may alter VE/VCO2 slope indirectly 
through increased leptin secretion into the blood stream.   
 Previous studies have reported a negative relationship between adiposity, serum 
leptin and the VE/VCO2 slope during non-weight bearing cycle exercise.11, 24, 28   In our 
study our subjects performed weight bearing exercise which has been shown to reduce 
minute ventilation and tidal volumes when compared to non-weight bearing exercise.30  A 
reduction in minute ventilation and tidal volume during weight bearing exercise places 
greater strain on cardiopulmonary system to meet metabolic demands.  Further, using a 
weight bearing exercise model in research may better represent the normal daily activities 
of obese adults and provide a better indication of the contributing mechanisms to 
hypoventilation.  
 We are the first to demonstrate that reduced ventilatory responses in obese females 
when compared to normal weight females during weight bearing exercise correlate with 
reduced serum LRe concentrations.  LRe has been described as a regulator of leptin’s 
bioavailability through several reported mechanisms including reduction of leptin transport 
into the central nervous system of mice.17, 29  In our obese group we observed reduced 
serum LRe concentrations and elevated serum leptin, which suggests greater serum 
concentrations of unbound leptin compared to our normal weight group.29  Based on the 
mouse model, the lower serum LRe concentration in the obese group would further 
indicate that leptin blood brain barrier transport was not impaired and that leptin was most 
likely present in the cerebral spinal fluid (CSF).17  If leptin transport into the CSF was not a 
limiting factor in our obese group than the reduced ventilatory responses in these subjects 
 55
   
may reflect central leptin resistance.  This idea is supported by our observation that the 
VE/VCO2 slope was reduced in our obese group and by the observation of others that 
central leptin resistance is related to elevated leptin and associated with reduced 
chemosensitivity to hypercapnia and hypoventilation in obese adults.11  If this 
interpretation is correct, our data also suggest the novel idea that reduced serum LRe in 
human obese females may be an index of the presence of central leptin resistance leading 
to reduced ventilatory responses.  This raises the important question of whether low serum 
LRe in obese subjects reflects low concentrations of central leptin receptors that are critical 
for leptin's central actions.     
 We were also interested in the amount of variance that truncal adiposity, leptin, and 
LRe accounted for in the VE/VCO2 slopes between the two groups.  Stepwise linear 
regression analysis revealed that truncal adiposity accounted for 31.5% of variance in 
ventilatory responses to exercise.  Leptin and LRe were statistically excluded from this 
analysis indicating that their relationship with the VE/VCO2 slope did not contribute any 
greater variance than truncal adiposity.  Our findings further explain the relationship 
between obesity, leptin, and ventilatory impairment by demonstrating that elevated truncal 
adiposity can alter normal ventilatory responses to exercise.11, 13, 24  However the 
ventilatory mechanisms altered by truncal adiposity appear to be independent of maximal 
minute ventilation.  
  Several limitations must be considered when interpreting the results of our study.  
First, we utilized VE/VCO2 slope as an indication of arterial gas concentration instead of 
actual arterial blood gas sampling.  Obtaining measurements of arterial concentrations of 
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oxygen and carbon dioxide may further describe the difference in VE/VCO2 slopes 
between the two groups.  Additionally, we can only infer to the relationship in our study 
between leptin, LRe, central chemosensors, and hypercapnia as it is not practical in human 
research to obtain samples in cerebral spinal fluid.  Our sample size may have been a 
limiting factor and a larger cohort may have contributed to greater statistical power.   
 In conclusion, we observed significantly reduced VE/VCO2 slopes in morbidly 
obese females during progressive weight bearing exercise when compared to normal 
weight females.  Truncal adiposity, serum leptin and soluble leptin receptor were all 
correlated with a diminished VE/VCO2 slope, however truncal adiposity accounted for the 
greatest variance in ventilatory responses to exercise.  Despite their relationship with the 
VE/VCO2 slope, both truncal adiposity and basal leptin were not correlated with minute 
ventilation, respiratory rate, and tidal volume.  This finding suggests that both truncal 
adiposity and leptin altered ventilation independent of any mechanical impairment.  In 
contrast, the soluble leptin receptor was both related to the VE/VCO2 slope and with minute 
ventilation.  LRe was significantly reduced in the obese group indicating that leptin 
transport in the central nervous system was not a limiting factor in exercise ventilation 
responses.  Rather, our obese group was leptin resistant and the resistance extended to the 
cardiorespiratory center significantly reducing ventilatory responses to carbon dioxide.   
We conclude that in obesity increased truncal adiposity, serum leptin and reduced serum 
LRe are associated with impaired ventilatory responses to exercise.     
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Figures and Tables  
 
Table I. Anthropometrics and blood markers between normal weight and obese groups. 
 
Variable 
 
NW  
N=12 
OB 
N=13 
P-value 
Age (years) 36.1 (±8.0) 37.7 (±11.4) 0.670 
Body weight (kg) 66.5 (±5.1) 116.6 (±16.5) 0.001* 
Height (cm) 170.4 (±5.3) 166.2 (±6.5) 0.090 
Body Mass Index (kg/m2) 22.8 (±1.2) 42.0 (±4.8) 0.001* 
Abdominal Girth (cm) 81.3 (±4.5) 120.8 (±13.1) 0.001* 
Waist Girth (cm) 73.2 (±3.2) 111.2 (±11.8) 0.001* 
Hip Girth (cm) 101.0 (±3.8) 134.7 (±10.7) 0.002* 
Waist:Hip Ratio 0.73 (±0.04) 0.83 (±.07) 0.050* 
Total Percent Fat (%) 29.9 (±4.0) 51.2 (±4.4) 0.001* 
Total Trunk Mass (kg) 19.1 (±3.0) 56.9 (±10.8) 0.001* 
Truncal Fat Mass (kg) 7.7 (±1.3) 34.5 (±6.7) 0.001* 
Truncal Lean Mass (kg) 19.1 (±1.5) 30.1 (±8.1) 0.001* 
Total Leptin (ng/ml) 9.0 (±3.9) 43.4 (±13.5) 0.001* 
LRe (ng/ml) 5.4 (±1.1) 3.1 (±0.5) 0.001  
 * Denotes significant difference (p ≤0.05) between  normal weight and obese group.  
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Table II. Cardiopulmonary responses to the exercise bout between the normal weight and 
obese groups.   
 
Variable NW 
N=12 
OB 
N=13 
P -value 
Total Exercise Duration (minutes) 21.5 (±1.6) 13.7 (±2.6) 0.001* 
VO2max (L/min) 2.29 (±0.4) 2.46 (±0.4) 0.407 
VO2max (ml/kg/min) 39.7 (±5.3) 21.4 (±4.3)  0.001* 
VEmax (L/min) 66.7 (±11.6) 59.7 (±11.8) 0.134 
Maximal Heart Rate (bt/min) 178.1 (±10.5) 170.2 (±16.3) 0.200 
Maximal Respiratory Rate (b/min) 42.2 (±5.8) 40.7 (±5.9) 0.559 
Maximal Lactate (mmol/L) 9.1 (±1.95) 6.8 (±1.87) 0.001* 
Maximal Rating of Perceived Exertion 19 (±1.0) 18 (±1.5) 0.788 
VTmax (L/min) 2.07 (±0.3) 2.14 (±0.5) 0.784 
VE/VCO2 slope 25.97 (±2.5) 22.28 (±2.9) 0.005* 
Data Presented as group means and standard deviations. 
* Denotes significant difference between normal weight and obese group at p ≤0.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table III. Stepwise linear regression with truncal adiposity as predictor variables on the 
dependent variable, ventilatory responses to exercise (VE/VCO2 Slope). Significance is set 
at p≤ 0.05. 
 
Dependent 
Variable 
Predictor R R2 P = SEE 
VE/VCO2 slope Truncal Adiposity .561 .315 0.004 2.80 
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Figure I. VE/VCO2 slope during progressive treadmill exercise from the normal weight 
group (NW) and the obese group (OB). 
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* Significant difference (p≤ 0.05) between NW and OB groups.  
 
Figure II. Fasting serum leptin concentrations prior to progressive treadmill exercise from 
the normal weight group (NW) and the obese group (OB). 
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* Significant difference (p≤ 0.05) between NW and OB groups.  
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Figure III. Fasting serum soluble leptin receptor (LRe) concentrations prior to progressive 
treadmill exercise from the normal weight group (NW) and the obese group (OB). 
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CHAPTER 4 Manuscript Two 
 
 
 
Title: The effects of Roux-en-Y gastric bypass surgery on the minute ventilation and 
carbon dioxide slope in morbidly obese women: association of truncal adiposity, serum 
leptin, and soluble leptin receptor.  
Abstract 
Background: Obesity is associated with increased truncal adiposity and endocrine 
inflammation and both alter ventilation.  Truncal adiposity impairs normal ventilatory 
mechanics during exercise.  Leptin is elevated in obesity and has been described as a 
central ventilatory stimulant and its bioavailability is regulated by the soluble leptin 
receptor (LRe) which is decreased in obesity.  Roux-en-Y gastric bypass surgery (RYGBS) 
is a weight loss intervention that improves body composition and several obesity related 
co-morbidities including exercise pulmonary ventilation during non-weight bearing 
exercise. The purpose of this study was to evaluate the effects of RYGBS on exercise 
ventilation (VE/VCO2 slope) truncal adiposity, serum leptin, and LRe during weight 
bearing exercise.  Methods: Nine morbidly obese females participated in this study (37.7 
±11.4 years, 42.0 ± 4.8 kg/m2).  Cardiopulmonary variables were measured during 
progressive treadmill walking prior to and 3 months following surgery. Fasting serum 
leptin, LRe, and truncal adiposity were measured pre-surgery and 1 and 3 months post 
surgery.  Results: Significant reductions in total adiposity, truncal adiposity, and serum 
leptin were observed at 1 and 3 months post RYGBS.  There were no changes in LRe or 
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VE/VCO2 slope at 3 months post RYGBS. Conclusion: Despite significant reductions in 
truncal adiposity and serum leptin there were no improvements in ventilatory responses to 
weight bearing exercise in morbidly obese females following RYGBS. It is possible that 
weight loss and subsequent improvements in serum leptin and truncal adiposity were 
insufficient to improve exercise ventilation during weight bearing exercise. 
Introduction 
 Obesity is a major public health concern with nearly a third of all Americans above 
their recommended body mass index (BMI).1  It has been well established that obesity is 
associated with an increased risk for cardiopulmonary and metabolic diseases, as well as 
some forms of cancer.2 In recent years, many Americans have sought treatment for obesity 
and its related co-morbidities by electing to undergo weight loss surgery, including Roux-
en-Y gastric bypass surgery (RYGBS).3  Reports have shown a steady increase in RYGBS 
procedures since 2000 in both males and females.4   RYGBS is a mal-absorptive and 
volume restricting surgery that produces up to ~70% of post surgical excess weight loss 
and near complete reversal of many obesity related co-morbidities within the first year 
following surgery.4   While the improvements in many co-morbid conditions have been 
well documented following RYGBS, few studies have evaluated the effects of weight loss 
following RYGBS on pulmonary ventilation.   
  Obesity has been shown to negatively impact both resting and exercising 
ventilation and several mechanisms, including elevated truncal adiposity and reduced 
central ventilatory drive, have been proposed to explain obesity-related pulmonary 
impairments.5-7  Exercise requires a rapid and responsive alteration in ventilatory rate and 
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volume to meet the changing metabolic demands from increased muscular activity.  The 
ventilatory response to exercise is often assessed by evaluating the slope of the rise in 
minute ventilation to a corresponding rise in carbon dioxide (VE/VCO2 slope).8  The 
VE/VCO2 slope indirectly quantifies the mechanical function of the lungs, chest wall, and 
inspiratory muscles along with the sensitivity of the central respiratory centers to 
hypercapnia.  As a prognostic tool, the VE/VCO2 slope provides a valuable assessment of 
cardiopulmonary responses to exercise as it is not dependent on individual effort.9   In 
obesity, chemosensitivity to exercise-induced hypercapnia is often diminished and 
ventilation fails to rise at a sufficient rate to maintain the desired work rate.10  This was 
demonstrated in a recent study when weight loss surgery improved VE/VCO2 slope, 
alveolar ventilation, and compensatory hyperventilation at 10 weeks following surgery.11  
A recent study also observed that the waist to hip ratio (WHR), an indirect marker of 
regional fat distribution, positively correlated with poor alveolar gas exchange.12  These 
combined findings demonstrated a possible link between truncal and total adiposity and 
ventilatory responses to exercise.   
   Recent evidence has indicated that adipose tissue induced mechanical impairments 
are not the only possible mechanisms effecting normal resting and exercising ventilation.6  
Several observations from both human and animal studies suggest that the inflammatory 
adipokine leptin may play a central role in ventilation.13, 14  Leptin, a peptide hormone 
secreted from adipose tissue, is primarily involved in appetite regulation and has been 
shown to be elevated several fold in obese individuals compared to normal weight 
controls.15  Hyperleptinemia is associated with a state of “leptin resistance” or reduced 
 68
   
leptin action at the end organ binding site and is believed to affect cardiopulmonary 
function.16   
 In a recent study, fasting leptin levels in obese subjects were associated with a 
diminished respiratory drive and hypercapnic response that was independent of adiposity.13  
Likewise, obese leptin deficient mice exhibit a reduced respiratory drive, respiratory rate, 
tidal volume, and diminished response to both hypoxia and hypercapnia that is reversed 
upon direct injection of leptin into the central nervous system (CNS).17  This suggests that 
leptin may function either directly or indirectly as a ventilatory stimulant.  A more recent 
study determined that obese rats responded with dose-dependent improvements in resting 
respiratory rate, rhythm and neural efferent signals following injections of leptin into the 
dorsal structures of the respiratory center.14  Unlike obese leptin deficient mice, human 
obesity is associated with high concentrations of serum leptin and reduced central action, a 
condition commonly described as leptin resistance.  In obesity, it is theorized that leptin 
resistance must extend to the cardiorespiratory center altering normal ventilation.  
Investigations into the potential mechanisms of leptin resistance suggest a link between the 
soluble leptin receptor (LRe) and leptin transcytosis into the CNS which may inhibit leptin 
transport across the blood brain barrier and contribute to reduced concentrations of leptin 
in the cerebral spinal fluid (CSF).18, 19 
 The purpose of this study was to evaluate the effects of short-term (3-month) 
weight loss following RYGBS on the ventilatory responses to progressive treadmill 
walking in morbidly obese females.  Additionally, measures of truncal adiposity, serum 
leptin, and the soluble leptin receptor were evaluated at 1 month and 3 months post-surgery 
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to further understand the factors that might contribute to improved ventilatory responses to 
graded exercise following weight loss.  We hypothesized that weight loss would result in 
improved VE/VCO2 slope and the changes would be associated with decreased truncal 
adiposity, reduced basal serum leptin concentration, and increased basal soluble leptin 
receptor concentration. 
Methods  
 Study Population 
 Female subjects were recruited through Virginia Commonwealth University’s 
(VCU) Surgical Weight Loss Center.  All subjects completed an informed consent prior to 
voluntary participation.  The study protocol was approved by the VCU’s Institutional 
Review Board.  To be included in the study subjects had to 1) be female, 2) have a BMI > 
40 kg/m2 or a BMI >35 kg/m2 with two or more co-morbidities, 3) be able to walk 
unassisted, 4) be scheduled to undergo laparoscopic Roux-en-Y gastric bypass surgery 
(RYGBS) at VCU Medical Center, and 5) be cleared by a cardiologist to undergo maximal 
exercise testing. Based on these criteria, 14 morbidly obese female RYGBS patients 
enrolled in the study.  Subjects were required to visit the VCU General Clinical Research 
Center on three separate occasions:  1) Pre-surgical visit within two weeks of their 
RYGBS, 2) 1-month post-surgery and 3) 3-months post-surgery.  During the 1-month post-
surgical visit, only anthropometric measurements and resting blood samples were obtained 
as patients were not medically cleared for maximal exercise. Subjects reported for each 
visit between the hours of 7:00 – 8:00 AM following and 8-hour fast. 
 Anthropometrics 
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 During each visit, height was measured to the nearest 0.5 cm using a fixed 
stadiometer and body weight was determined to the nearest 0.5 kg using a digital scale.  
Abdominal, waist, and hip circumference measures were assessed at standard anatomical 
locations to the nearest 0.5 cm.20  Waist to hip ratio and body mass index (kg/m2) values 
were determined by standard calculations. 
 Body Composition 
 Whole and regional quantities of adipose tissue and lean mass were obtained from 
dual energy x-ray absorptiometry analysis (DXA; GE Lunar, iDXA, United Kingdom).  
Truncal adiposity and lean tissue percentages (without bone mineral content) were 
manually determined from iDXA software calculations based on the following 
standardized anatomical sites: 1) upper body superior limits were the soft tissue boundary 
of the shoulders excluding the neck and head, 2) lateral boundaries began at the 
glenohumeral joints and continued along the soft tissue of the trunk with separation 
between the arms, 3) the inferior boundary of the trunk was established from the most 
superior point of the suprailiac crest. 
 Blood Analysis 
 A 7-ml resting blood sample was obtained via venapuncture from an antecubital 
vein with a 21 gauge Vacutainer® blood collection set into a serum separator tube 
(Vacutainer, BD Inc, Franklin Lakes, NJ).  After 30 minutes at room temperature, the 
whole blood sample was centrifuged at 1000x g for 15 minutes.  Following separation, 
serum samples were aliquoted into sample tubes and frozen (-80° C) until later analysis.  
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 Measurement of leptin and soluble leptin receptor were performed using 
Quantikine ELISA kits per manufacturer specifications (R&D Systems, Inc, Minneapolis, 
MN).  A microplate reader with an absorbance wavelength of 450 nm and automatic 
correction wavelength of 540 nm (Bio-Rad 680 XR, Bio-Rad Laboratories, Hercules, CA) 
was utilized to analyze all samples.  Samples were run in duplicate and the intra assay 
correlations of variation for each assay were averaged at 5.75% with all standard curve 
correlation coefficients > 0.998.  A single capillary blood sample was collected from the 
finger 1-minute following exercise test termination for determination of maximal lactate 
response (Lactate Scout handheld analyzer SensLab, Leipzig, Germany). 
 Cardiopulmonary Testing 
 Subjects performed a progressive maximal treadmill walking test until volitional 
fatigue.  The treadmill protocol consisted of a 4 minute warm up at 2.0 MPH at 0% grade 
followed by 2 minute stages at 2.5 MPH at 0% grade and 3.0 MPH at 0% grade.  
Subsequent 2 minute stages maintained 3.0 MPH and increased grade by 2.5% every 2 
minutes until the subject was no longer able to maintain the treadmill pace. 
 Each subject was monitored with a 12-lead EKG during the graded exercise test.  
Heart rate was obtained at the end of every minute and blood pressure and ratings of 
perceived exertion (6-20 Borg scale) was obtained at the end of every stage.  Continuous 
breath by breath measurement of VO2 (L/min-1 & ml/kg/min-1), VCO2 (L/min-1), VE (STPD 
L/min-1), VT (L/min-1), respiratory rate (breaths per minute), and RER (VCO2/ VO2)  was 
obtained during the exercise test (Vmax Encore, Sensormedics, Yorba Linda, CA). All 
cardiorespiratory variables were averaged over 20 seconds for analysis.  Maximal oxygen 
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consumption (VO2max L/min-1 & ml/kg/min-1) was determined as the highest 20 sec 
averaged oxygen consumption value.  Maximal lactate > 8.0 mM, maximal RPE > 18, 
maximal RER > 1.15, and a maximal HR value within ± 10 beats per minute of age-
predicted maximal heart rate (220 – age) were used to assess subject effort during the 
graded exercise test. 
 Derived variables 
 The VE (STPD L/min-1)/VCO2 (L/min-1) slope was determined by least squares 
linear regression (y = a + bx) with 20 second averages from the entire exercise bout.  
Changes in truncal adiposity, leptin and LRe were determined as the difference between 3 
month and pre values.  Maximal oxygen uptake relative to fat free mass was calculated as 
the absolute VO2 multiplied by 1000 and divided by the total lean mass in kilograms. 
 Statistical Analysis 
 Analysis for differences between pre, 1 month and 3 months post-surgery 
anthropometrics and blood markers were performed using a repeated measures analysis of 
variance.  Post hoc analysis was performed using Tukey’s HSD.  Determination of of pre-
surgery and 3 month post-surgery difference in exercise variables were performed with 
paired samples T-test.  Person Product Moment correlations were utilized to evaluate 
relationships among truncal adiposity, leptin, LRe, and cardiorespiratory variables.  
Statistical significance was set at a p ≤ 0.05.  All statistical analyses were performed using 
SPSS 17.0 statistical software (SPSS Inc., Chicago, IL). 
Results 
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 Fourteen morbidly obese females (37.7 ±11.4 years, 42.1 ±4.8 kg/m2) enrolled in 
the study.  One subject was not included in the final analyses due to failure to reach any of 
the required criteria for a maximal exercise test.  Four additional subjects did not perform 
their 1 month and 3 month post-surgery trials due to scheduling conflicts, reducing the 
final sample size to 9 subjects.  All results are reported as mean (± SD). 
 Anthropometrics 
 Changes in anthropometric variables following gastric bypass surgery are provided 
in Table I.  At 1-month post-surgery, there  was a significant decrease in BMI (p= 0.006 ) 
and total body fat percentage (p< 0.001); however, there were no significant decreases in 
body mass, truncal fat mass, or waist to hip ratio. At 3 months post-surgery significant 
differences were observed in total body mass (p = 0.005), waist (p= 0.01) hip (p= 0.002), 
and abdominal (p= 0.049) circumferences, truncal adiposity (p= 0.006), and truncal lean 
tissue mass (p= 0.023).   
 Leptin and soluble leptin receptor 
 Compared to pre-surgical values, leptin was significantly reduced at both 1 month 
(Pre 38.8 ±7.5, 1 month 28.8 ±12.1 ng/ml, p= 0.03) and 3 months post-surgery (Pre 38.8 
±7.5, 3 month 21.8 ±12.2 ng/ml p = 0.003) (Figure I).  There were no differences between 
1 and 3 month serum leptin concentrations.  There were no significant differences in the 
concentration of soluble leptin receptor across time (Figure II).   
 Cardiopulmonary Responses 
 Cardiopulmonary variables obtained prior to surgery and at 3 months post-surgery 
are provided in Table II.  There were no significant differences in VE/VCO2 slopes (p= 
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0.70), maximal respiratory exchange ratio (p= 0.13), relative (p= 0.18) and absolute (p= 
0.07) peak oxygen uptake, maximal oxygen uptake relative to fat free mass (p= 0.632), 
maximal heart rate (p= 0.73) maximal minute ventilation (p= 0.20), maximal tidal volume 
(p= 0.57) or respiratory rate (p= 0.19).   
 Person Product Moment Correlations 
 Pre- surgery leptin was correlated with BMI (r=.689 p= 0.009), abdominal 
circumference (r=.609 p= 0.02), and truncal adiposity (r=.647 p= 0.01).  Pre-surgery 
truncal adiposity was correlated with BMI (r=.830 p= 0.000), and abdominal 
circumference (r=.863 p< 0.001).  At 1 month post-surgery leptin was correlated with BMI 
(r=.656 p= 0.04), waist circumference (r=.732 p= 0.01), and truncal adiposity (r=.711 p= 
0.02).   One month truncal adiposity was correlated with waist circumference (r=.778 p= 
0.008) and abdominal circumference (r=.780 p= 0.008).   Pre-surgery, 1 month and 3 
months post serum LRe was not correlated with any measured cardiorespiratory variable of 
intent.  There were no significant correlations between changes in leptin (r= .486 p= 0.18), 
soluble leptin receptor (r=-.157, p= 0.68), and truncal fat mass (r= -.132, p= 0.73) and 
VE/VCO2 slope at 3 months post-surgery. 
 Discussion 
 This study evaluated post-surgical changes in truncal adiposity, basal serum leptin 
and the soluble leptin receptor, and ventilatory responses during weight bearing exercise.  
Several recent studies have observed that both chest wall impairment from adipose tissue 
and blunted ventilatory responses to hypercapnia alter ventilation in obese adults.7, 13  
Several previous reports have evaluated obesity related ventilatory impairments during 
 75
   
non-weight bearing cycle exercise.11, 13  In contrast, this study aimed to evaluate ventilatory 
responses following RYGBS during weight bearing exercise.  Despite significant 
reductions in leptin and truncal fat mass 3 months post-surgery, ventilatory responses to 
carbon dioxide, as assessed by the VE/VCO2 slope, were not improved during treadmill 
walking.  Additionally, soluble leptin receptor, which is thought to influence blood brain 
barrier transport of leptin, was not significantly increased 3-months post-surgery.  
Furthermore, we observed no relationships between the change in VE/VCO2 slope and 
reduction in truncal fat mass, basal serum leptin, or LRe at 3 months post-surgery.  
 Our findings are in contrast to a recent study that observed that a 21 kg (16%) 
reduction of total body mass improved pulmonary gas exchange, compensatory 
hyperventilation and VE/VCO2 slope at 10 weeks following gastric bypass surgery.11  We 
observed a 23 kg (24%) reduction of total body mass and nearly 5 kg of truncal adiposity 
reductions that did not alter the VE/VCO2 slope.  The differences between our findings and 
previous reports may be our group experienced no improvements in tidal volume, minute 
ventilation or respiratory rate at 3 months post surgery (Figure 3).  Zavorsky et al. reported 
significantly improved tidal volumes at 10 weeks post surgery, which may account for the 
subsequent improved alveolar gas diffusion and compensatory hyperventilation.  We 
observed no significant difference in tidal volume within our group.  It is possible that 
gender difference may have contributed partly to our lack of agreement. In the Zavorsky et 
al. report, 26% of their subjects were males, which have been reported to have poorer 
alveolar gas exchange than females and thus may have benefited the greatest from post 
surgery improvement in truncal adiposity.11, 12   Lastly, we utilized a weight-bearing 
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exercise protocol which may exacerbate ventilation impairments to a greater extent that 
non-weight bearing exercise.   
 Several reports have implicated hyperleptinemia as an indication of reduced 
chemosensitivity to hypercapnia during exercise in obese adults.6, 13  Rising hypercapnia is 
a primary stimulus that drives ventilation during exercise and subsequent reductions in 
sensitivity may alter reduce ventilatory responses to exercise (VE/VCO2 slope).9, 21  In 
obesity, elevated basal leptin is associated with blunted hypercapnic response and elevated 
partial pressures of arterial carbon dioxide at rest and during exercise.13, 17  We observed 
significantly reduced serum leptin levels of 26% at 1 month post surgery and nearly 44% at 
3 months post surgery.  Reductions in leptin were associated with decreases in total 
adiposity, truncal adiposity and body mass index.  However, there were no improvements 
in 3 month post surgery VE/VCO2 slopes despite changes in leptin.  Previous reports 
showing improvements in respiration following reductions in serum leptin also reported 
subsequent improvements in respiratory rate and tidal volume.14  We observed no 
improvement in any ventilation marker despite significant reductions in serum leptin.  
Therefore, it is possible, that in our cohort, at 3 months post surgery the observed fat mass 
and leptin reductions were not sufficient to improve exercise ventilation.  This suggests 
that 3 months post RYGBS may have been too soon to observe any pulmonary changes as 
a result of the reductions in fat mass and leptin concentrations.  A previous report observed 
the greatest median improvements in resting arterial gas partial pressures, lung volumes 
and inspiratory and expiratory function were at 26 months post surgery.24  Suggesting that 
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in our group a greater post-operative time was required to measure any significant 
improvements in ventilatory responses to exercise. 
 We were also interested in the changes in the soluble leptin receptor (LRe) 
following RYGBS.  LRe is reduced in obese adults in comparison to normal weight 
controls and this condition is reversed in obese individuals during severe caloric 
restriction.22  Previous studies have suggested that LRe regulates leptin transport across the 
blood brain barrier and a reduction in LRe contributes to obesity-related leptin resistance.19  
In our subjects, LRe did not change at either post-surgical time points, suggesting that even 
a fairly rapid weight loss of 21 kg in the first 3-month after RYGBS was not sufficient to 
reverse the obesity-related reductions in LRe.  Our results are surprising as RYGBS is both 
a mal-absorptive and volume restricting surgery that significantly alters the daily caloric 
intake of the patient to 800-1000 calories per day.   LRe concentrations in females with 
anorexia nervosa and following 3 weeks of very low calorie diets of 550 calories (VLCD) 
have been previously evaluated.22, 23  Increased levels of LRe were observed in anorexic 
females when compared to normal weight controls.  Likewise, increased LRe was observed 
in obese adults following 3 weeks of a VLCD when compared to control subjects.  These 
combined findings indicate that with nutritional deficit LRe synthesis appears to be up 
regulated.  Similarly, RYGBS produces weight loss through a significant caloric deficit 
that favors the mobilization and metabolism of stored adipose tissue.  It is possible that 
mechanisms other than significant caloric deficit regulate systemic LRe concentrations in 
morbidly obese females.   
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 Our results were limited by our subject drop out rate which affected our sample 
size at 3 months post exercise.  We also attempted to quantify pulmonary improvements in 
gas diffusion through the VE/VCO2 slope and not with arterial gas sampling.  The additions 
of arterial gas concentrations may have aided in further understand why VE/VCO2 slopes 
did not change in our group.  Despite the challenges with arterial blood sampling, we may 
have further explained the potential changes in exercise ventilation following RYGBS.  
Lastly, we did not perform any baseline pulmonary tests which may have contributed to 
our understanding of the potential pulmonary improvements observed post surgery.   
 In conclusion, we observed that ventilatory responses to exercise (VE/VCO2 slope) 
were not improved 3-months post-GBS, even though truncal adiposity and serum leptin 
were significantly reduced.  Our results are in contrast to previous reports that adiposity 
and basal leptin levels modify exercise ventilation in obesity.  We also observed no 
significant reductions in soluble leptin receptor and LRe which had previously been shown 
to be increased during prolong nutritional deficits and weight loss, as is accomplished 
following RYGBS.  Lastly, it is possible that 3 months post surgery changes in adiposity 
and serum leptin were not substantial enough for an improvement in ventilatory responses 
during weight bearing exercise.  Future research is needed to describe the pulmonary 
differences between weight-bearing and non-weight bearing exercise in morbidly obese 
females beyond the 3 month post-operative time point.   
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Figures and Graphs 
Table I. Anthropometrics measures obtained from morbidly obese females prior to, 1 
month and 3 months following RYGBS. 
Variable Pre-Surgery 
 
(N=9) 
1 month Post-Surgery 
(N=9) 
3 month Post-
Surgery 
(N=9) 
Body weight (kg) 119.2 (±11.4) 105.8 (12.5)   96.2 (13.1)* 
Body Mass Index (kg/m2) 43.0 (±4.1) 36.8 (4.7)*  34.9 (4.2)* 
Abdominal Girth (cm) 120.2 (±11.8) 113.2 (10.3) 105.4 (15.0) 
Waist Girth (cm) 109.7 (±9.7) 104.9 (8.2)   96.5 (9.4)* 
Hip Girth (cm) 136.2 (±8.4) 128.0 (9.9) 120.1 (±9.4)* 
Waist to Hip Ratio 0.808 (±0.1) 0.824 (.01)    0.79 (0.1) 
Total Fat (kg) 59.8 (±9.0) 51.5 (±8.4)*    44.7 (±9.1)* 
Total Percent Fat 52.7 (±3.7) 50.9 (2.4)*    49.6 (4.2)* 
Truncal Fat Mass (kg) 34.5 (±4.3) 29.0 (4.3)   24.6 (4.6)* 
Truncal Lean Mass (kg) 28.8 (±3.1) 27.1 (2.9)   23.2 (2.5)* 
Data presented as means ± standard derivations significant.  
* Significantly different (p ≤ 0.05 ) than pre-surgery.  
 
 
 
 
Table II.  Group cardiorespiratory measures obtained from morbidly obese females prior 
to and 3 months following RYGBS. 
 
 Variable  Pre-Surgery 
(N=9) 
3 month  
Post-Surgery 
(N=9) 
Total Exercise Duration (minutes) 13.8 (±2.8) 15.3 (±3.3) 
VO2max (L/min) 2.49 (±0.5) 2.28 (±0.3) 
VO2max (ml/kg/min) 21.1 (±4.8) 24.5 (±5.2) 
VEmax (L/min) 59.0 (±11.3) 58.6 (±5.7) 
Heart Rate Max (BPM) 173.6 (±15.0) 171.7 (±11.7) 
VO2max  (ml/kgffm/min) 48.7 (±9.5) 47.8 (±8.4) 
RERmax  1.03 (±0.1) 1.10 (±0.1) 
VTmax (L/min) 2.12 (±.6) 2.09 (±.52) 
VE/VCO2 slope 21.6 (±2.4) 22.01 (±3.4) 
Data presented as means ± standard derivations significant.  
* Significantly different (p ≤ 0.05.) than pre-surgery.  
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Figure I. Serum leptin concentrations obtained from morbidly obese females prior to, 1 
month and 3 months following RYGBS.  
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* indicates significance (p ≤ 0.05) from pre-surgery concentrations. 
 
 
Figure II. Serum soluble leptin receptor (LRe) concentrations obtained from morbidly 
obese females prior to, 1 month and 3 months following RYGBS. 
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* indicates significance (p ≤ 0.05) from pre-surgery concentrations. 
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Figure III.  Pre and 3 month post-surgery ventilatory response to exercise obtained from 
morbidly obese females prior to and 3 months following RYGBS.  Dark bar indicates 
group means at pre-surgery and 3 months post-surgery. 
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